UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM N-CSR
CERTIFIED SHAREHOLDER REPORT
OF
REGISTERED MANAGEMENT INVESTMENT COMPANIES
Investment Company Act file number: 811-01530
Name of Registrant: | Vanguard Explorer Fund |
Address of Registrant: | P.O. Box 2600 |
| Valley Forge, PA 19482 |
Name and address of agent for service: | Anne E. Robinson, Esquire |
| P.O. Box 876 |
| Valley Forge, PA 19482 |
Registrant’s telephone number, including area code: (610) 669-1000
Date of fiscal year end: October 31
Date of reporting period: November 1, 2020—October 31, 2021
Item 1: Reports to Shareholders
Annual Report | October 31, 2021
Vanguard Explorer™ Fund
Contents
Your Fund’s Performance at a Glance
| 1 |
Advisors' Report
| 2 |
About Your Fund’s Expenses
| 8 |
Performance Summary
| 10 |
Financial Statements
| 12 |
Please note: The opinions expressed in this report are just that—informed opinions. They should not be considered promises or advice. Also, please keep in mind that the information and opinions cover the period through the date on the front of this report. Of course, the risks of investing in your fund are spelled out in the prospectus.
Your Fund’s Performance at a Glance
• | Vanguard Explorer Fund returned 46.27% for Investor Shares and 46.42% for Admiral Shares for the 12 months ended October 31, 2021. The fund outperformed its benchmark, the Russell 2500 Growth Index, which returned 37.12%. |
• | The global economy continued to recover from the sharp pandemic-induced contraction in the spring of 2020. Countries that have been more successful in containing the virus have generally fared better economically. Swift, extensive fiscal and monetary support from policymakers has also been a key to the rebound. Even amid concerns toward the end of the fiscal year about inflation and the prospect of less accommodative monetary policy, stock returns for the period were excellent. |
• | Growth stocks underperformed their value counterparts, while small- and mid-capitalization stocks surpassed large-caps. |
• | Ten of the fund’s 11 sectors contributed positively to performance, with health care, financials, and materials producing the strongest results. Our stock selection in consumer discretionary detracted slightly. |
Market Barometer
| Average Annual Total Returns Periods Ended October 31, 2021 |
| One Year | Three Years | Five Years |
Stocks | | | |
Russell 1000 Index (Large-caps) | 43.51% | 22.01% | 19.16% |
Russell 2000 Index (Small-caps) | 50.80 | 16.47 | 15.52 |
Russell 3000 Index (Broad U.S. market) | 43.90 | 21.62 | 18.91 |
FTSE All-World ex US Index (International) | 30.23 | 12.42 | 10.05 |
Bonds | | | |
Bloomberg U.S. Aggregate Bond Index (Broad taxable market) | -0.48% | 5.63% | 3.10% |
Bloomberg Municipal Bond Index (Broad tax-exempt market) | 2.64 | 5.17 | 3.41 |
FTSE Three-Month U.S. Treasury Bill Index | 0.05 | 1.08 | 1.12 |
CPI | | | |
Consumer Price Index | 6.22% | 3.03% | 2.73% |
For the 12 months ended October 31, 2021, Vanguard Explorer Fund returned 46.27% for Investor Shares and 46.42% for Admiral Shares. It outperformed its benchmark, the Russell 2500 Growth Index, which returned 37.12%.
Your fund is managed by five independent advisors, a strategy that enhances its diversification by providing exposure to distinct yet complementary investment approaches. It’s not uncommon for different advisors to have different views about individual securities or the broader investment environment.
The table on pages 6–7 lists the advisors, the amount and percentage of fund assets each manages, and brief descriptions of their investment strategies.
The advisors have provided the following assessment of the investment environment during the past 12 months and the notable successes and shortfalls in their portfolios. These comments were prepared on November 12, 2021.
Wellington Management Company LLP
Portfolio Manager:
Daniel J. Fitzpatrick, CFA, Senior Managing
Director and Equity Portfolio Manager
During the 12 months ended October 31, 2021, small-capitalization stocks posted strong positive results, as measured by the Russell 2000 Index, and outperformed their large-cap counterparts.
Market performance was driven by broad macroeconomic factors, including accommodative monetary and fiscal policy, increasing COVID-19 vaccination rates, and strong demand for goods and services. However, volatility also remained elevated during the period, driven by investor concerns about rising inflation and interest rates, the pace of economic growth, and uncertainty about fiscal stimulus and the federal debt ceiling.
Our bottom-up stock selection contributed to results in 10 of 11 sectors, most notably in financials, information technology, and consumer discretionary. Strong stock selection was partially offset by weaker selection in health care. Sector allocation, a result of our selection process, also contributed to relative results. Our underweight to health care and overweights to industrials and financials contributed to relative returns. Our underweight to information technology partially detracted from results.
Western Alliance, a multi-bank holding company, was the top relative contributor during the 12 months. Shares ended the period higher as the stock price surged in the first quarter of 2021 after the company reported strong 2020 fourth-quarter earnings. Both loans and deposits showed robust growth, and net interest income beat consensus expectations on improving credit trends. Investors also viewed Western Alliance's acquisition of AmeriHome as helping future earnings.
LHC Group, a hospice and home health care services company, was the biggest detractor during the period. Shares declined sharply in the third quarter after the company reported earnings. Revenue missed consensus expectations, and the company faced increasing operating margin headwinds.
Management also noted mounting labor pressures in the industry, as the company tries to hire and retain clinicians amid staffing shortages. We continue to own the stock as we expect the company will continue to benefit from long-term structural trends, including greater demand for home health care and potential increased partnerships with hospitals.
We remain excited about the portfolio holdings and are confident that individual company fundamentals will be the key driver of returns over the long term, with the market ultimately rewarding those with high-quality management teams, competitive differentiation, and strong balance sheets.
ClearBridge Investments, LLC
Portfolio Managers:
Brian Angerame,Managing Director
Aram Green, Managing Director
Jeffrey Russell, CFA, Managing Director
Matthew Lilling, CFA, Director
The Russell 2500 Growth benchmark returned 37.12% during the extraordinary year ended October 31, 2021. Equities
rose unabated after “Vaccine Monday” (November 9, 2020, when Pfizer and BioNTech reported the efficacy of their vaccine) until mid-February. The emergence of COVID-19 variants unsettled markets, which meandered during the balance of the fiscal year before closing at record highs
Against the backdrop of COVID-19 outbreaks, a number of fundamental trends created uncertainty for stocks. Positive factors included good earnings growth compared with a difficult 2020, benign interest rates, and strong vaccine effectiveness that enabled further reopening of the economy.
Negative influences included the unresolved U.S. fiscal situation and concomitant monetary and tax policy; shortages caused by supply chain problems, which resulted in inflation and surprise negative revisions; an overall slowing of macroeconomic growth; and events beyond U.S. borders such as Chinese regulatory policy, the massive debt problems that Chinese property company Evergrande faced, and the U.S. withdrawal from Afghanistan.
The portfolio’s health care, financial, and communication services investments contributed to outperformance relative to the benchmark. Cybersecurity leader Fortinet was the portfolio’s largest contributor, followed by SVB Financial and Etsy. A variety of companies that enable biopharmaceutical research and development contributed to the strong outperformance in health care.
We remain optimistic about the portfolio’s companies and are confident in their ability to steer through the myriad challenges that have confronted companies this year.
Stephens Investment Management Group, LLC
Portfolio Manager:
Ryan E. Crane, CFA,
Chief Investment Officer
The far-reaching ramifications of COVID-19 continued to dominate headlines and the market environment. While the first half of the 12 months under review was influenced most by the virus’ direct impact on the market and the economy, investors have been focused more recently on the second-order effects of supply chain disruptions and inflationary pressures.
We initially were well-prepared and quick to respond to the COVID-19 situation. As the public health situation improved with vaccine rollouts early in 2021, investors became increasingly enthusiastic about the economy’s reopening. Cyclical stocks, and those particularly hurt by the pandemic, rallied the most. Our bias toward high-quality, secular-growth stocks was a slight headwind initially. However, as the Delta variant slowed the recovery and as inflation started to increase, our positioning began to pay off.
Most of our relative outperformance came from health care—where we have avoided the unprofitable, early-stage biotechnology companies. Our exposure
to life sciences companies generated strong returns. While we did very well in technology in absolute terms, it was difficult to keep up with returns. This was true particularly in the semiconductor industry, where shortages have driven much higher prices, even for commodity products.
We believe inflation is likely to persist longer than the market consensus is predicting, and the complex economic conditions we face today are likely to yield many investment opportunities.
Vanguard Quantitative Equity Group
Portfolio Manager:
Cesar Orosco, CFA
The world economy’s recovery from the 2020 pandemic-induced contraction was quicker than many had expected. Countries that have been better at containing the virus have generally been more successful economically. Quick, far-reaching support from policymakers has also been vital to the rebound.
Because the 12 months under review reflect the recovery in stocks following the sharp downturn at the start of the pandemic, results were excellent. The Russell 3000 Index, the benchmark for the entire U.S. stock market, returned 43.90% for the period. In the United States, where the fund concentrates its investments, small- and mid-capitalization stocks outpaced large-caps, and value stocks returned more than growth stocks.
Although it’s important to understand how overall performance is affected by such macroeconomic factors, our approach to investing focuses on several key characteristics, including high quality—healthy balance sheets and steady cash-flow generation; effective management decisions—sound investment policies that favor internal over external funding; consistent earnings growth—ability to grow earnings year after year; strong market sentiment—market confirmation of our view; and reasonable valuation—shares that are not overpriced. During the period, we added a sixth criterion, a defensive model that evaluates heavily shorted stocks, as this can signal concerns over future company prospects.
Using these six themes, we generate a daily composite stock ranking. We then monitor our portfolio based on those rankings and adjust when appropriate to maximize expected returns while minimizing exposure to risks that our research indicates don’t improve returns.
Over the 12 months ended October 31, 2021, our value, defensive, and growth models contributed to our relative performance, while our quality, sentiment (or momentum), and management decisions models detracted. Our positions in all 11 industry sectors contributed positively to performance on a relative basis. The strongest sector results were in information technology (IT), driven in part by strong stock selection in software companies. Selection in health care and materials was also strong.
At the stock level, top contributors included overweight positions in Atkore, in industrials; Workiva, Domo, and Atlassian, in IT; and Tenet Healthcare. Underweight positions in Plug Power, in industrials, and MongoDB and Entegris, in IT, detracted, as did overweight positions to Sarepta Therapeutics and Bluebird Bio in health care.
ArrowMark Partners
Portfolio Managers:
Chad Meade, Partner
Brian Schaub, CFA, Partner
Investment environment
At the start of the period, rising COVID-19 infection rates, shuttered economies, and U.S. presidential election-related anxiety made it difficult for the world to look to the future with optimism. However, growing optimism about a return to normalcy, accelerating COVID-19 vaccine distribution, and the passage of an additional $1.9 trillion U.S. relief package propelled U.S. equity markets to new highs during the first part of 2021. As the year progressed, investor optimism was overshadowed by worries about the emergence of new COVID-19 variants, supply chain constraints, labor shortages, and inflation
Successes and shortfalls
Our positions in information technology delivered the largest positive contribution to performance. Manufacturer ON Semiconductor and application software company J2 Global were beneficial.
Specific holdings in the consumer discretionary sector detracted from performance as used-car online platform Vroom and educational technology company 2U declined during the period.
Market environment
We believe the markets will remain focused on the pace of bond purchase tapering and the timeline for interest rate
increases. With supply chains strained and consumer demand strong, future increases seem more likely than not. We believe a possible inflation spiral would introduce even more volatility into the markets and pressure some of the extreme valuations we see in the information technology and health care sectors.
Vanguard Explorer Fund Investment Advisors
|
| Fund Assets Managed | |
Investment Advisor | % | $ Million | Investment Strategy |
Wellington Management Company LLP | 35 | 8,823 | Conducts research and analysis of individual companies to select stocks believed to have exceptional growth potential relative to their market valuations. Each stock is considered individually before purchase, and company developments are continually monitored for comparison with expectations for growth. |
ClearBridge Investments, LLC | 17 | 4,222 | The firm seeks to invest in cash-generative, quality growth companies that are category leaders (or have the ability to become market leaders), and display capital allocation discipline aimed at fueling long-term sustainable growth. ClearBridge focuses on cash flow based metrics to value companies, as well as revenue or earnings multiples, relying on the most appropriate valuation metrics for each company. This approach aligns with the team’s style of investing in cash generative, quality growth companies. The research process is disciplined and collaborative, with each member of the team executing on a shared investment philosophy and process. |
Stephens Investment Management Group, LLC | 16 | 3,840 | Employs a disciplined, bottom-up investment selection process that combines rigorous fundamental analysis with quantitative screening to identify companies with superior earnings growth potential. The approach screens for core growth stocks and for catalyst stocks. Core growth stocks have strong growth franchises, recurring revenue, and above-average growth rates; catalyst stocks are experiencing changes that could lead to accelerated earnings growth. |
Vanguard Quantitative Equity Group | 16 | 3,837 | Employs a quantitative fundamental management approach, using models that assess valuation, growth prospects, management decisions, market sentiment, earnings and balance-sheet quality, and shorting intensity of companies as compared with their peers. |
|
| Fund Assets Managed | |
Investment Advisor | % | $ Million | Investment Strategy |
ArrowMark Partners | 15 | 3,600 | The firm employs a “risk-before-reward“ investment strategy and in-depth fundamental research to uncover companies that, in its opinion, can control environments. The portfolio managers start by identifying businesses with strong competitive advantages in industries with high barriers to entry and then narrow their focus to companies with large potential markets and high-quality business models focused on the future. Across this entire investment process, the team takes steps to deliver strong downside protection, resulting in a diversified portfolio of 75–100 stocks. |
Cash Investments | 1 | 346 | These short-term reserves are invested by Vanguard in equity index products to simulate investment in stocks. Each advisor may also maintain a modest cash position. |
About Your Fund’s Expenses
As a shareholder of the fund, you incur ongoing costs, which include costs for portfolio management, administrative services, and shareholder reports (like this one), among others. Operating expenses, which are deducted from a fund’s gross income, directly reduce the investment return of the fund.
A fund’s expenses are expressed as a percentage of its average net assets. This figure is known as the expense ratio. The following examples are intended to help you understand the ongoing costs (in dollars) of investing in your fund and to compare these costs with those of other mutual funds. The examples are based on an investment of $1,000 made at the beginning of the period shown and held for the entire period.
The accompanying table illustrates your fund’s costs in two ways:
• | Based on actual fund return. This section helps you to estimate the actual expenses that you paid over the period. The ”Ending Account Value“ shown is derived from the fund‘s actual return, and the third column shows the dollar amount that would have been paid by an investor who started with $1,000 in the fund. You may use the information here, together with the amount you invested, to estimate the expenses that you paid over the period. |
To do so, simply divide your account value by $1,000 (for example, an $8,600 account value divided by $1,000 = 8.6), then multiply the result by the number given for your fund under the heading ”Expenses Paid During Period.“
• | Based on hypothetical 5% yearly return. This section is intended to help you compare your fund‘s costs with those of other mutual funds. It assumes that the fund had a yearly return of 5% before expenses, but that the expense ratio is unchanged. In this case—because the return used is not the fund’s actual return—the results do not apply to your investment. The example is useful in making comparisons because the Securities and Exchange Commission requires all mutual funds to calculate expenses based on a 5% return. You can assess your fund’s costs by comparing this hypothetical example with the hypothetical examples that appear in shareholder reports of other funds. |
Note that the expenses shown in the table are meant to highlight and help you compare ongoing costs only and do not reflect transaction costs incurred by the fund for buying and selling securities. Further, the expenses do not include any purchase, redemption, or account service fees described in the fund prospectus. If such fees were applied to your account, your costs would be higher. Your fund does not carry a “sales load.”
The calculations assume no shares were bought or sold during the period. Your actual costs may have been higher or lower, depending on the amount of your investment and the timing of any purchases or redemptions.
You can find more information about the fund’s expenses, including annual expense ratios, in the Financial Statements section of this report. For additional information on operating expenses and other shareholder costs, please refer to your fund’s current prospectus.
Six Months Ended October 31, 2021 | | | |
| Beginning Account Value 4/30/2021 | Ending Account Value 10/31/2021 | Expenses Paid During Period |
Based on Actual Fund Return | | | |
Explorer Fund | | | |
Investor Shares | $1,000.00 | $1,053.30 | $2.07 |
Admiral™ Shares | 1,000.00 | 1,053.90 | 1.50 |
Based on Hypothetical 5% Yearly Return | | | |
Investor Shares | $1,000.00 | $1,023.19 | $2.04 |
Admiral Shares | 1,000.00 | 1,023.74 | 1.48 |
The calculations are based on expenses incurred in the most recent six-month period. The fund’s annualized six-month expense ratios for that period are 0.40% for Investor Shares and 0.29% for Admiral Shares. The dollar amounts shown as “Expenses Paid” are equal to the annualized expense ratio multiplied by the average account value over the period, multiplied by the number of days in the most recent six-month period, then divided by the number of days in the most recent 12-month period (184/365).
All of the returns in this report represent past performance, which is not a guarantee of future results that may be achieved by the fund. (Current performance may be lower or higher than the performance data cited. For performance data current to the most recent month-end, visit our website at vanguard.com/performance.) Note, too, that both investment returns and principal value can fluctuate widely, so an investor’s shares, when sold, could be worth more or less than their original cost. The returns shown do not reflect taxes that a shareholder would pay on fund distributions or on the sale of fund shares.
Cumulative Performance: October 31, 2011, Through October 31, 2021
Initial Investment of $10,000
| | Average Annual Total Returns Periods Ended October 31, 2021 | |
| | One Year | Five Years | Ten Years | Final Value of a $10,000 Investment |
![](https://capedge.com/proxy/N-CSR/0001104659-21-154147/img1b0307573.jpg) | Explorer Fund Investor Shares | 46.27% | 21.24% | 16.00% | $44,123 |
![](https://capedge.com/proxy/N-CSR/0001104659-21-154147/img5f7a622a4.jpg) | Russell 2500 Growth Index | 37.12 | 20.68 | 16.11 | 44,534 |
![](https://capedge.com/proxy/N-CSR/0001104659-21-154147/imgbe2162dc5.jpg) | Dow Jones U.S. Total Stock Market Float Adjusted Index | 44.07 | 18.87 | 16.04 | 44,284 |
| | | |
| | One Year | Five Years | Ten Years | Final Value of a $50,000 Investment |
Explorer Fund Admiral Shares | 46.42% | 21.37% | 16.15% | $223,510 |
Russell 2500 Growth Index | 37.12 | 20.68 | 16.11 | 222,670 |
Dow Jones U.S. Total Stock Market Float Adjusted Index | 44.07 | 18.87 | 16.04 | 221,419 |
See Financial Highlights for dividend information.
Communication Services | 3.0% |
Consumer Discretionary | 13.4 |
Consumer Staples | 2.6 |
Energy | 1.4 |
Financials | 8.8 |
Health Care | 21.6 |
Industrials | 19.5 |
Information Technology | 22.8 |
Materials | 2.1 |
Real Estate | 3.0 |
Utilities | 0.5 |
Other | 1.3 |
The table reflects the fund’s investments, except for short-term investments and derivatives. Sector categories are based on the Global Industry Classification Standard (“GICS”), except for the “Other” category (if applicable), which includes securities that have not been provided a GICS classification as of the effective reporting period.
Global Industry Classification Standard (“GICS”) was developed by and is the exclusive property and a service mark of MSCI Inc. (“MSCI”) and Standard and Poor’s, a division of McGraw-Hill Companies, Inc. (“S&P”), and is licensed for use by Vanguard. Neither MSCI, S&P nor any third party involved in making or compiling the GICS or any GICS classification makes any express or implied warranties or representations with respect to such standard or classification (or the results to be obtained by the use thereof), and all such parties hereby expressly disclaim all warranties of originality, accuracy, completeness, merchantability or fitness for a particular purpose with respect to any such standard or classification. Without limiting any of the foregoing, in no event shall MSCI, S&P, any of its affiliates or any third party involved in making or compiling the GICS or any GICS classification have any liability for any direct, indirect, special, punitive, consequential or any other damages (including lost profits) even if notified of the possibility of such damages.
The fund files its complete schedule of portfolio holdings with the Securities and Exchange Commission (SEC) for the first and third quarters of each fiscal year as an exhibit to its reports on Form N-PORT. The fund’s Form N-PORT reports are available on the SEC’s website at www.sec.gov.
| | Shares | Market Value•
($000) |
Common Stocks (97.0%) |
Communication Services (2.9%) |
* | Live Nation Entertainment Inc. | 1,313,389 | 132,849 |
* | Cinemark Holdings Inc. | 3,792,861 | 71,306 |
| New York Times Co. Class A | 1,253,184 | 68,411 |
* | Take-Two Interactive Software Inc. | 291,712 | 52,800 |
* | Cargurus Inc. | 1,359,118 | 45,585 |
* | Cardlytics Inc. | 567,150 | 44,612 |
* | Match Group Inc. | 262,641 | 39,601 |
* | IAC/InterActiveCorp. | 242,443 | 36,941 |
| Warner Music Group Corp. Class A | 730,951 | 36,175 |
| Electronic Arts Inc. | 236,116 | 33,115 |
* | ZipRecruiter Inc. Class A | 1,071,581 | 29,769 |
* | Bandwidth Inc. Class A | 299,694 | 25,558 |
* | Roku Inc. | 51,772 | 15,785 |
* | Iridium Communications Inc. | 352,422 | 14,291 |
* | TechTarget Inc. | 148,109 | 13,968 |
* | Playtika Holding Corp. | 444,723 | 12,577 |
* | Yelp Inc. Class A | 236,280 | 9,127 |
| Nexstar Media Group Inc. Class A | 60,358 | 9,049 |
* | Zynga Inc. Class A | 750,142 | 5,536 |
* | Madison Square Garden Sports Corp. | 18,823 | 3,567 |
*,1 | Skillz Inc. Class A | 288,190 | 3,222 |
*,1 | Gogo Inc. | 151,515 | 2,464 |
| Sinclair Broadcast Group Inc. Class A | 83,495 | 2,182 |
* | Clear Channel Outdoor Holdings Inc. | 515,480 | 1,495 |
* | Globalstar Inc. | 905,122 | 1,493 |
* | Magnite Inc. | 47,752 | 1,291 |
* | EverQuote Inc. Class A | 73,361 | 1,012 |
* | IDT Corp. Class B | 19,546 | 945 |
* | AMC Networks Inc. Class A | 18,335 | 730 |
* | WideOpenWest Inc. | 32,919 | 627 |
| | | 716,083 |
Consumer Discretionary (13.0%) |
* | Burlington Stores Inc. | 621,787 | 171,794 |
* | Under Armour Inc. Class C | 6,355,040 | 119,983 |
* | Skyline Champion Corp. | 1,796,396 | 113,748 |
| | Shares | Market Value•
($000) |
* | Ollie's Bargain Outlet Holdings Inc. | 1,623,460 | 109,843 |
* | Etsy Inc. | 436,405 | 109,402 |
* | Skechers USA Inc. Class A | 2,276,139 | 105,180 |
| Steven Madden Ltd. | 2,293,322 | 103,429 |
*,2 | Houghton Mifflin Harcourt Co. | 6,382,762 | 90,571 |
| Levi Strauss & Co. Class A | 3,333,950 | 87,283 |
| Carter's Inc. | 885,205 | 87,210 |
| Wingstop Inc. | 504,337 | 86,983 |
* | Five Below Inc. | 397,392 | 78,405 |
| Acushnet Holdings Corp. | 1,519,598 | 77,408 |
* | Sally Beauty Holdings Inc. | 4,773,796 | 72,848 |
| Hanesbrands Inc. | 4,199,678 | 71,563 |
* | Deckers Outdoor Corp. | 160,823 | 63,575 |
* | 2U Inc. | 2,104,407 | 62,164 |
* | frontdoor Inc. | 1,608,336 | 59,959 |
* | Farfetch Ltd. Class A | 1,518,293 | 59,532 |
* | Floor & Decor Holdings Inc. Class A | 433,605 | 58,936 |
* | Chegg Inc. | 959,487 | 57,032 |
| Papa John's International Inc. | 412,257 | 51,153 |
*,1 | Chewy Inc. Class A | 652,029 | 49,424 |
* | Vroom Inc. | 2,499,244 | 47,811 |
* | Revolve Group Inc. | 636,740 | 47,781 |
| Domino's Pizza Inc. | 95,090 | 46,496 |
* | Leslie's Inc. | 2,234,927 | 46,218 |
* | Grand Canyon Education Inc. | 560,264 | 44,653 |
* | Dollar Tree Inc. | 400,682 | 43,178 |
* | National Vision Holdings Inc. | 687,868 | 42,400 |
| Pool Corp. | 79,423 | 40,916 |
| La-Z-Boy Inc. | 1,217,401 | 40,466 |
* | Ulta Beauty Inc. | 109,644 | 40,279 |
| Shutterstock Inc. | 323,408 | 39,181 |
* | Purple Innovation Inc. Class A | 2,013,377 | 38,858 |
| Ralph Lauren Corp. Class A | 276,182 | 35,122 |
* | Callaway Golf Co. | 1,228,772 | 33,238 |
* | RealReal Inc. | 2,493,206 | 32,487 |
* | Petco Health & Wellness Co. Inc. Class A | 1,300,002 | 32,149 |
| Garmin Ltd. | 203,915 | 29,282 |
* | Bright Horizons Family Solutions Inc. | 167,797 | 27,854 |
| | Shares | Market Value•
($000) |
*,1 | Canada Goose Holdings Inc. | 642,164 | 23,824 |
| Williams-Sonoma Inc. | 123,852 | 23,003 |
| Polaris Inc. | 189,907 | 21,830 |
* | Coursera Inc. | 617,730 | 21,565 |
* | Crocs Inc. | 123,883 | 20,001 |
* | Fox Factory Holding Corp. | 114,943 | 18,500 |
* | Scientific Games Corp. Class A | 230,325 | 18,438 |
| Tapestry Inc. | 458,686 | 17,880 |
* | Sportradar Holding AG Class A | 842,298 | 17,604 |
| Texas Roadhouse Inc. Class A | 193,016 | 17,142 |
| Signet Jewelers Ltd. | 186,120 | 16,598 |
| Tempur Sealy International Inc. | 332,251 | 14,775 |
* | GameStop Corp. Class A | 78,413 | 14,390 |
* | Boyd Gaming Corp. | 219,803 | 14,019 |
| Wendy's Co. | 538,600 | 12,011 |
* | Everi Holdings Inc. | 461,549 | 11,077 |
| Rent-A-Center Inc. | 202,316 | 10,775 |
* | Urban Outfitters Inc. | 331,063 | 10,571 |
* | Abercrombie & Fitch Co. Class A | 237,788 | 9,402 |
| Columbia Sportswear Co. | 87,639 | 9,100 |
* | Dave & Buster's Entertainment Inc. | 244,177 | 9,066 |
* | Gentherm Inc. | 122,406 | 9,013 |
| Winnebago Industries Inc. | 127,240 | 8,613 |
* | SeaWorld Entertainment Inc. | 134,117 | 8,516 |
| H&R Block Inc. | 357,561 | 8,249 |
* | Six Flags Entertainment Corp. | 199,183 | 8,192 |
* | Tenneco Inc. Class A | 603,877 | 8,013 |
* | Dine Brands Global Inc. | 92,115 | 7,785 |
* | Overstock.com Inc. | 81,089 | 7,722 |
* | Red Rock Resorts Inc. Class A | 141,311 | 7,689 |
* | XPEL Inc. | 101,115 | 7,675 |
* | Sleep Number Corp. | 85,206 | 7,527 |
* | Brinker International Inc. | 174,030 | 7,302 |
* | Children's Place Inc. | 86,376 | 7,160 |
| PulteGroup Inc. | 148,276 | 7,129 |
* | YETI Holdings Inc. | 69,494 | 6,833 |
| Hibbett Inc. | 88,082 | 6,821 |
| Churchill Downs Inc. | 26,249 | 6,037 |
* | Master Craft Boat Holdings Inc. | 194,458 | 5,208 |
| Oxford Industries Inc. | 55,745 | 5,169 |
* | Stitch Fix Inc. Class A | 146,469 | 5,068 |
| Caleres Inc. | 195,485 | 4,508 |
* | Tri Pointe Homes Inc. | 185,793 | 4,494 |
* | Ruth's Hospitality Group Inc. | 227,403 | 4,398 |
| Jack in the Box Inc. | 43,836 | 4,338 |
* | Sonos Inc. | 132,861 | 4,334 |
* | American Axle & Manufacturing Holdings Inc. | 466,464 | 4,236 |
| Buckle Inc. | 91,762 | 3,819 |
* | Perdoceo Education Corp. | 354,118 | 3,761 |
* | Boot Barn Holdings Inc. | 32,689 | 3,416 |
* | Lumber Liquidators Holdings Inc. | 181,642 | 3,284 |
| Century Communities Inc. | 40,327 | 2,704 |
| | Shares | Market Value•
($000) |
| Wolverine World Wide Inc. | 77,576 | 2,573 |
| Standard Motor Products Inc. | 49,905 | 2,391 |
* | Academy Sports & Outdoors Inc. | 54,150 | 2,317 |
* | Visteon Corp. | 20,235 | 2,290 |
* | Neogames SA | 59,624 | 2,215 |
* | Kirkland's Inc. | 90,271 | 2,029 |
* | MarineMax Inc. | 37,308 | 1,932 |
* | RH | 2,820 | 1,860 |
| Shoe Carnival Inc. | 49,873 | 1,689 |
* | Chico's FAS Inc. | 287,524 | 1,570 |
* | Citi Trends Inc. | 19,885 | 1,538 |
* | Golden Entertainment Inc. | 29,044 | 1,509 |
* | Bloomin' Brands Inc. | 63,915 | 1,382 |
* | Vivint Smart Home Inc. | 152,159 | 1,380 |
* | Red Robin Gourmet Burgers Inc. | 67,430 | 1,340 |
| Aaron's Co. Inc. | 55,989 | 1,310 |
* | Cheesecake Factory Inc. | 32,135 | 1,306 |
| Vail Resorts Inc. | 3,554 | 1,225 |
* | Lovesac Co. | 14,860 | 1,159 |
| Gentex Corp. | 31,593 | 1,118 |
* | Groupon Inc. Class A | 42,614 | 904 |
| Patrick Industries Inc. | 10,262 | 800 |
* | Dorman Products Inc. | 7,510 | 784 |
* | Malibu Boats Inc. Class A | 9,402 | 664 |
* | Funko Inc. Class A | 39,011 | 639 |
* | WW International Inc. | 19,685 | 342 |
| | | 3,214,644 |
Consumer Staples (2.5%) |
* | Performance Food Group Co. | 2,542,278 | 114,987 |
* | BJ's Wholesale Club Holdings Inc. | 1,666,239 | 97,375 |
* | Nomad Foods Ltd. | 3,504,711 | 95,433 |
| Nu Skin Enterprises Inc. Class A | 1,824,547 | 73,256 |
| Casey's General Stores Inc. | 266,643 | 51,073 |
| MGP Ingredients Inc. | 549,568 | 35,288 |
* | Olaplex Holdings Inc. | 888,230 | 24,790 |
| Coca-Cola Consolidated Inc. | 58,182 | 23,354 |
* | Darling Ingredients Inc. | 197,045 | 16,654 |
* | Herbalife Nutrition Ltd. | 341,214 | 15,832 |
* | Oatly Group AB ADR | 967,400 | 12,470 |
* | BellRing Brands Inc. Class A | 371,394 | 9,961 |
| Vector Group Ltd. | 679,282 | 9,007 |
| Medifast Inc. | 37,605 | 7,381 |
* | Pilgrim's Pride Corp. | 214,595 | 6,043 |
| John B Sanfilippo & Son Inc. | 67,616 | 5,714 |
* | USANA Health Sciences Inc. | 49,637 | 4,818 |
| National Beverage Corp. | 64,370 | 3,630 |
| Turning Point Brands Inc. | 50,998 | 1,947 |
| Albertsons Cos. Inc. Class A | 48,316 | 1,495 |
* | United Natural Foods Inc. | 31,380 | 1,362 |
| | | 611,870 |
Energy (1.4%) |
* | Whiting Petroleum Corp. | 1,185,021 | 77,180 |
| Magnolia Oil & Gas Corp. Class A | 3,619,565 | 75,577 |
| | Shares | Market Value•
($000) |
* | ChampionX Corp. | 1,448,898 | 38,005 |
| Viper Energy Partners LP | 1,652,764 | 36,444 |
| Pioneer Natural Resources Co. | 103,134 | 19,284 |
| Ovintiv Inc. (XNYS) | 503,335 | 18,885 |
| Coterra Energy Inc. | 755,303 | 16,103 |
* | Southwestern Energy Co. | 2,583,787 | 12,609 |
| Diamondback Energy Inc. | 90,451 | 9,696 |
* | Delek US Holdings Inc. | 445,157 | 8,658 |
* | Callon Petroleum Co. | 150,868 | 7,804 |
* | Laredo Petroleum Inc. | 99,992 | 7,539 |
| Texas Pacific Land Corp. | 5,728 | 7,296 |
* | Denbury Inc. | 74,711 | 6,325 |
* | Kosmos Energy Ltd. | 1,315,322 | 4,735 |
| Matador Resources Co. | 17,141 | 717 |
| | | 346,857 |
Financials (8.6%) |
* | SVB Financial Group | 232,265 | 166,627 |
| LPL Financial Holdings Inc. | 950,851 | 155,959 |
| Synovus Financial Corp. | 2,582,150 | 120,302 |
| Assured Guaranty Ltd. | 1,979,361 | 110,013 |
| Western Alliance Bancorp | 889,042 | 103,209 |
| MGIC Investment Corp. | 6,337,340 | 102,411 |
| Tradeweb Markets Inc. Class A | 1,122,453 | 100,011 |
| Hannon Armstrong Sustainable Infrastructure Capital Inc. | 1,653,077 | 99,846 |
| Voya Financial Inc. | 1,419,245 | 99,021 |
| Webster Financial Corp. | 1,686,269 | 94,364 |
| American Financial Group Inc. | 685,638 | 93,274 |
| Prosperity Bancshares Inc. | 1,189,799 | 89,604 |
| Sterling Bancorp | 3,449,086 | 87,779 |
| Assurant Inc. | 525,119 | 84,707 |
* | Green Dot Corp. Class A | 1,515,413 | 64,193 |
| Houlihan Lokey Inc. Class A | 510,467 | 57,213 |
* | Silvergate Capital Corp. Class A | 299,152 | 46,853 |
| PROG Holdings Inc. | 1,098,813 | 44,447 |
* | PRA Group Inc. | 956,062 | 40,996 |
* | Palomar Holdings Inc. | 401,579 | 36,724 |
| MarketAxess Holdings Inc. | 83,870 | 34,275 |
| WisdomTree Investments Inc. | 4,896,168 | 31,286 |
| Piper Sandler Cos. | 168,193 | 27,700 |
* | Ryan Specialty Group Holdings Inc. Class A | 606,654 | 22,925 |
| Primerica Inc. | 134,402 | 22,612 |
| Bank OZK | 454,598 | 20,307 |
* | Upstart Holdings Inc. | 62,933 | 20,267 |
| SLM Corp. | 1,078,192 | 19,785 |
* | Credit Acceptance Corp. | 29,904 | 17,889 |
| Virtus Investment Partners Inc. | 42,398 | 13,567 |
| Moelis & Co. Class A | 171,565 | 12,480 |
| Walker & Dunlop Inc. | 87,519 | 11,384 |
* | Enova International Inc. | 304,985 | 9,894 |
| Kinsale Capital Group Inc. | 44,749 | 8,375 |
| Brightsphere Investment Group Inc. | 270,769 | 8,118 |
| Cowen Inc. Class A | 210,668 | 7,948 |
| | Shares | Market Value•
($000) |
* | Texas Capital Bancshares Inc. | 123,129 | 7,462 |
| Brown & Brown Inc. | 112,810 | 7,119 |
| Meta Financial Group Inc. | 59,362 | 3,291 |
| Universal Insurance Holdings Inc. | 206,778 | 3,054 |
| Everest Re Group Ltd. | 7,600 | 1,987 |
| PJT Partners Inc. Class A | 19,739 | 1,614 |
| StepStone Group Inc. Class A | 32,121 | 1,509 |
| Pacific Premier Bancorp Inc. | 19,243 | 808 |
| FactSet Research Systems Inc. | 1,742 | 773 |
| | | 2,113,982 |
Health Care (20.9%) |
* | ICON plc | 1,043,673 | 299,294 |
* | Omnicell Inc. | 1,076,825 | 191,836 |
* | Charles River Laboratories International Inc. | 361,762 | 162,315 |
* | Molina Healthcare Inc. | 471,328 | 139,381 |
* | Acadia Healthcare Co. Inc. | 2,081,623 | 129,061 |
* | Insulet Corp. | 402,427 | 124,760 |
| STERIS plc | 524,480 | 122,592 |
| Bio-Techne Corp. | 223,501 | 117,036 |
* | Hologic Inc. | 1,559,606 | 114,335 |
* | Repligen Corp. | 355,878 | 103,383 |
* | Catalent Inc. | 746,969 | 102,977 |
* | ABIOMED Inc. | 293,141 | 97,335 |
* | Penumbra Inc. | 349,479 | 96,648 |
* | Avantor Inc. | 2,228,907 | 90,003 |
* | Veracyte Inc. | 1,877,537 | 89,896 |
* | Haemonetics Corp. | 1,265,338 | 86,941 |
* | Globus Medical Inc. Class A | 1,107,902 | 85,497 |
* | LHC Group Inc. | 625,168 | 84,141 |
* | Merit Medical Systems Inc. | 1,210,764 | 81,436 |
* | Horizon Therapeutics plc | 669,904 | 80,328 |
* | Amedisys Inc. | 467,088 | 79,097 |
| Hill-Rom Holdings Inc. | 500,720 | 77,561 |
* | Syneos Health Inc. | 758,784 | 70,825 |
* | Kodiak Sciences Inc. | 574,758 | 67,298 |
* | Integra LifeSciences Holdings Corp. | 965,457 | 64,164 |
* | Ultragenyx Pharmaceutical Inc. | 751,380 | 63,056 |
* | IDEXX Laboratories Inc. | 93,215 | 62,094 |
* | Tandem Diabetes Care Inc. | 444,783 | 60,637 |
* | HealthEquity Inc. | 915,599 | 60,594 |
* | DexCom Inc. | 94,898 | 59,141 |
* | Maravai LifeSciences Holdings Inc. Class A | 1,369,473 | 57,915 |
* | Allakos Inc. | 502,922 | 50,584 |
* | Mettler-Toledo International Inc. | 32,775 | 48,536 |
* | Exelixis Inc. | 2,247,664 | 48,347 |
| ResMed Inc. | 171,664 | 45,132 |
* | Mirati Therapeutics Inc. | 238,314 | 45,046 |
* | Myriad Genetics Inc. | 1,428,723 | 43,962 |
* | Glaukos Corp. | 934,488 | 42,715 |
* | Quidel Corp. | 320,003 | 42,487 |
* | Inovalon Holdings Inc. Class A | 1,001,904 | 40,868 |
* | AMN Healthcare Services Inc. | 399,182 | 39,399 |
| | Shares | Market Value•
($000) |
* | Ascendis Pharma A/S ADR | 239,806 | 36,357 |
* | Neogen Corp. | 841,693 | 35,612 |
* | Henry Schein Inc. | 466,404 | 35,610 |
* | Cano Health Inc. | 3,168,481 | 34,822 |
* | Stevanato Group SPA | 1,316,623 | 33,798 |
| Bruker Corp. | 394,652 | 31,691 |
* | Neurocrine Biosciences Inc. | 293,414 | 30,929 |
* | ALX Oncology Holdings Inc. | 548,551 | 30,741 |
* | Arena Pharmaceuticals Inc. | 526,953 | 30,242 |
* | Ligand Pharmaceuticals Inc. | 203,738 | 29,733 |
* | Y-mAbs Therapeutics Inc. | 1,209,598 | 29,708 |
* | 10X Genomics Inc. Class A | 183,145 | 29,536 |
* | Pacira BioSciences Inc. | 557,637 | 29,153 |
* | Apellis Pharmaceuticals Inc. | 920,333 | 28,291 |
* | Sotera Health Co. | 1,113,322 | 27,499 |
*,1 | Doximity Inc. Class A | 388,760 | 27,011 |
* | Nevro Corp. | 234,307 | 26,650 |
* | Turning Point Therapeutics Inc. | 623,157 | 25,911 |
* | Align Technology Inc. | 41,048 | 25,629 |
* | Halozyme Therapeutics Inc. | 666,081 | 25,358 |
* | MEDNAX Inc. | 921,608 | 25,095 |
| Chemed Corp. | 50,545 | 24,375 |
* | Axogen Inc. | 1,577,807 | 23,967 |
| Cerner Corp. | 314,623 | 23,373 |
* | Adagio Therapeutics Inc. | 785,259 | 22,961 |
* | CareDx Inc. | 448,798 | 22,889 |
* | NuVasive Inc. | 414,493 | 22,117 |
* | Medpace Holdings Inc. | 96,883 | 21,949 |
* | Supernus Pharmaceuticals Inc. | 727,620 | 21,719 |
* | C4 Therapeutics Inc. | 484,333 | 21,514 |
* | Agios Pharmaceuticals Inc. | 448,128 | 21,062 |
* | Deciphera Pharmaceuticals Inc. | 613,792 | 20,494 |
* | REVOLUTION Medicines Inc. | 695,291 | 20,462 |
| PerkinElmer Inc. | 113,546 | 20,085 |
* | Heron Therapeutics Inc. | 1,782,068 | 19,621 |
* | STAAR Surgical Co. | 163,636 | 19,384 |
* | Sage Therapeutics Inc. | 478,803 | 19,324 |
* | Sarepta Therapeutics Inc. | 232,940 | 18,433 |
* | Novavax Inc. | 116,833 | 17,388 |
| Cooper Cos. Inc. | 41,425 | 17,271 |
* | Exact Sciences Corp. | 175,526 | 16,714 |
* | SpringWorks Therapeutics Inc. | 243,960 | 16,360 |
* | Relay Therapeutics Inc. | 486,731 | 16,184 |
| Select Medical Holdings Corp. | 481,146 | 15,984 |
* | Illumina Inc. | 38,391 | 15,935 |
* | Veeva Systems Inc. Class A | 48,445 | 15,358 |
* | Viking Therapeutics Inc. | 2,460,104 | 14,318 |
* | Enanta Pharmaceuticals Inc. | 163,291 | 14,019 |
* | iRhythm Technologies Inc. | 194,678 | 13,655 |
* | Natera Inc. | 112,600 | 12,901 |
* | Travere Thrapeutics Inc. | 395,087 | 11,382 |
| | Shares | Market Value•
($000) |
* | Arvinas Inc. | 130,495 | 11,298 |
* | Alkermes plc | 366,419 | 11,099 |
* | Inspire Medical Systems Inc. | 40,519 | 10,923 |
* | Ionis Pharmaceuticals Inc. | 340,374 | 10,848 |
* | Tenet Healthcare Corp. | 148,573 | 10,647 |
* | Intellia Therapeutics Inc. | 78,484 | 10,437 |
* | ModivCare Inc. | 61,332 | 9,983 |
* | Agenus Inc. | 2,523,285 | 9,689 |
| Encompass Health Corp. | 147,233 | 9,358 |
* | Blueprint Medicines Corp. | 75,557 | 8,499 |
* | MacroGenics Inc. | 431,583 | 8,429 |
* | Ortho Clinical Diagnostics Holdings plc Class H | 418,147 | 8,267 |
* | Atara Biotherapeutics Inc. | 519,272 | 8,038 |
* | Tivity Health Inc. | 289,116 | 7,234 |
* | ImmunoGen Inc. | 1,190,122 | 7,176 |
| Ensign Group Inc. | 87,656 | 6,838 |
* | Community Health Systems Inc. | 510,579 | 6,689 |
* | Joint Corp. | 72,839 | 6,372 |
* | CytomX Therapeutics Inc. | 1,067,482 | 6,330 |
* | Shockwave Medical Inc. | 29,223 | 6,245 |
* | Option Care Health Inc. | 213,416 | 5,833 |
* | Precision BioSciences Inc. | 611,650 | 5,805 |
* | ACADIA Pharmaceuticals Inc. | 320,256 | 5,749 |
* | Akebia Therapeutics Inc. | 1,981,661 | 5,687 |
* | Fortress Biotech Inc. | 1,732,308 | 5,647 |
* | Vanda Pharmaceuticals Inc. | 324,929 | 5,563 |
* | Biohaven Pharmaceutical Holding Co. Ltd. | 38,214 | 5,439 |
* | Apria Inc. | 142,381 | 5,329 |
*,1 | Figs Inc. Class A | 155,323 | 5,220 |
* | Meridian Bioscience Inc. | 273,724 | 5,149 |
*,1 | Talis Biomedical Corp. | 946,340 | 5,063 |
*,1 | Clovis Oncology Inc. | 1,133,242 | 4,907 |
* | PTC Therapeutics Inc. | 117,544 | 4,458 |
* | Twist Bioscience Corp. | 36,313 | 4,314 |
* | Inari Medical Inc. | 45,330 | 4,103 |
* | Bluebird Bio Inc. | 173,134 | 4,053 |
* | Affimed NV | 592,606 | 4,030 |
| US Physical Therapy Inc. | 36,819 | 3,971 |
* | Puma Biotechnology Inc. | 777,390 | 3,965 |
*,1 | Ocugen Inc. | 333,006 | 3,943 |
* | AtriCure Inc. | 49,809 | 3,739 |
* | FibroGen Inc. | 329,220 | 3,661 |
* | Pacific Biosciences of California Inc. | 125,467 | 3,322 |
* | Ovid therapeutics Inc. | 940,320 | 3,197 |
*,1 | Intercept Pharmaceuticals Inc. | 189,212 | 3,190 |
* | Radius Health Inc. | 143,225 | 3,094 |
* | Emergent BioSolutions Inc. | 64,032 | 3,052 |
* | Sutro Biopharma Inc. | 150,023 | 3,024 |
* | Codexis Inc. | 84,450 | 2,936 |
* | RadNet Inc. | 89,046 | 2,768 |
* | Pennant Group Inc. | 101,356 | 2,592 |
* | Quanterix Corp. | 50,537 | 2,558 |
* | Seres Therapeutics Inc. | 419,871 | 2,553 |
* | Personalis Inc. | 126,241 | 2,477 |
* | Infinity Pharmaceuticals Inc. | 972,852 | 2,471 |
* | Denali Therapeutics Inc. | 49,329 | 2,385 |
*,1 | Esperion Therapeutics Inc. | 265,969 | 2,378 |
| | Shares | Market Value•
($000) |
* | Sangamo Therapeutics Inc. | 287,893 | 2,338 |
* | Anavex Life Sciences Corp. | 124,590 | 2,335 |
* | ICU Medical Inc. | 9,472 | 2,218 |
* | Molecular Templates Inc. | 424,818 | 2,218 |
* | Vir Biotechnology Inc. | 56,981 | 2,150 |
*,1 | Cassava Sciences Inc. | 49,215 | 2,123 |
* | Fate Therapeutics Inc. | 38,443 | 2,068 |
* | Inogen Inc. | 51,839 | 2,055 |
| Owens & Minor Inc. | 56,793 | 2,038 |
* | Lexicon Pharmaceuticals Inc. | 382,691 | 2,024 |
* | Protagonist Therapeutics Inc. | 62,425 | 1,945 |
* | Mustang Bio Inc. | 864,161 | 1,936 |
* | Selecta Biosciences Inc. | 528,838 | 1,899 |
* | REGENXBIO Inc. | 52,874 | 1,874 |
*,1 | Atossa Therapeutics Inc. | 698,520 | 1,795 |
* | Amneal Pharmaceuticals Inc. | 325,809 | 1,789 |
* | Sesen Bio Inc. | 1,461,872 | 1,769 |
* | Minerva Neurosciences Inc. | 1,241,858 | 1,739 |
* | Prothena Corp. plc | 30,703 | 1,699 |
* | ZIOPHARM Oncology Inc. | 1,105,848 | 1,659 |
* | Silk Road Medical Inc. | 28,212 | 1,656 |
* | Voyager Therapeutics Inc. | 457,063 | 1,655 |
* | Surgery Partners Inc. | 38,739 | 1,594 |
* | Allscripts Healthcare Solutions Inc. | 115,239 | 1,588 |
* | Vocera Communications Inc. | 27,954 | 1,582 |
* | Organogenesis Holdings Inc. Class A | 143,772 | 1,579 |
* | NanoString Technologies Inc. | 32,290 | 1,560 |
* | Athenex Inc. | 602,458 | 1,530 |
* | Endo International plc | 337,491 | 1,434 |
* | NextCure Inc. | 171,519 | 1,410 |
| West Pharmaceutical Services Inc. | 3,141 | 1,350 |
* | Editas Medicine Inc. Class A | 36,482 | 1,340 |
* | PAVmed Inc. | 241,990 | 1,314 |
* | Theravance Biopharma Inc. | 167,969 | 1,305 |
* | Sana Biotechnology Inc. | 60,449 | 1,254 |
* | Cutera Inc. | 29,037 | 1,249 |
* | Xencor Inc. | 30,194 | 1,194 |
* | Co-Diagnostics Inc. | 143,082 | 1,175 |
*,1 | vTv Therapeutics Inc. Class A | 820,390 | 1,173 |
* | Castle Biosciences Inc. | 18,657 | 1,163 |
* | Rapt Therapeutics Inc. | 33,154 | 1,047 |
* | Precigen Inc. | 216,409 | 1,045 |
* | Alector Inc. | 47,973 | 1,043 |
*,1 | Retractable Technologies Inc. | 107,784 | 1,020 |
* | Kiniksa Pharmaceuticals Ltd. Class A | 97,334 | 1,011 |
* | VBI Vaccines Inc. | 344,562 | 999 |
* | Syros Pharmaceuticals Inc. | 236,590 | 977 |
* | Spero Therapeutics Inc. | 54,307 | 954 |
* | Arrowhead Pharmaceuticals Inc. | 14,785 | 944 |
* | Vaxart Inc. | 139,045 | 933 |
| | Shares | Market Value•
($000) |
* | Cue Biopharma Inc. | 74,522 | 910 |
* | MannKind Corp. | 180,550 | 850 |
* | Amphastar Pharmaceuticals Inc. | 45,367 | 847 |
* | Omeros Corp. | 132,583 | 831 |
* | Corcept Therapeutics Inc. | 44,841 | 807 |
* | 1Life Healthcare Inc. | 37,256 | 807 |
* | Cross Country Healthcare Inc. | 38,107 | 790 |
* | Aldeyra Therapeutics Inc. | 86,259 | 785 |
* | Fulgent Genetics Inc. | 9,376 | 777 |
* | Tactile Systems Technology Inc. | 22,060 | 761 |
* | Mersana Therapeutics Inc. | 84,339 | 722 |
| | | 5,167,887 |
Industrials (18.9%) |
* | Trex Co. Inc. | 1,646,231 | 175,159 |
* | TriNet Group Inc. | 1,698,738 | 171,997 |
* | Clean Harbors Inc. | 1,497,861 | 168,569 |
* | Middleby Corp. | 892,771 | 162,877 |
* | Builders FirstSource Inc. | 2,138,210 | 124,594 |
* | RBC Bearings Inc. | 503,672 | 117,824 |
| Matson Inc. | 1,300,899 | 108,339 |
* | AerCap Holdings NV | 1,767,122 | 104,331 |
| Fortune Brands Home & Security Inc. | 1,000,482 | 101,449 |
* | Kirby Corp. | 1,926,143 | 100,949 |
* | Mercury Systems Inc. | 1,902,818 | 98,071 |
* | Sensata Technologies Holding plc | 1,741,483 | 95,956 |
| SPX FLOW Inc. | 1,271,584 | 95,000 |
| GATX Corp. | 959,213 | 90,981 |
| Kennametal Inc. | 2,283,998 | 90,789 |
| John Bean Technologies Corp. | 602,162 | 88,969 |
| Ritchie Bros Auctioneers Inc. | 1,294,796 | 88,499 |
* | Fluor Corp. | 4,516,658 | 87,804 |
| Acuity Brands Inc. | 421,321 | 86,552 |
* | Kornit Digital Ltd. | 491,741 | 82,258 |
| Spirit AeroSystems Holdings Inc. Class A | 1,970,553 | 81,364 |
* | United Rentals Inc. | 207,830 | 78,790 |
* | Masonite International Corp. | 634,940 | ��� 76,199 |
| Zurn Water Solutions Corp. | 2,052,584 | 74,468 |
* | Generac Holdings Inc. | 144,302 | 71,943 |
| EnerSys | 890,982 | 71,314 |
| Regal Rexnord Corp. | 457,646 | 69,713 |
* | Gibraltar Industries Inc. | 1,063,520 | 69,299 |
| IDEX Corp. | 308,180 | 68,592 |
| TransUnion | 592,363 | 68,294 |
| Science Applications International Corp. | 759,235 | 68,164 |
* | SiteOne Landscape Supply Inc. | 285,354 | 67,047 |
2 | Enerpac Tool Group Corp. Class A | 3,138,204 | 65,557 |
| BWX Technologies Inc. | 1,153,425 | 65,445 |
| CH Robinson Worldwide Inc. | 658,831 | 63,900 |
* | Chart Industries Inc. | 356,588 | 63,302 |
| Tennant Co. | 654,223 | 51,985 |
| Rush Enterprises Inc. Class A | 985,531 | 51,326 |
* | API Group Corp. | 2,315,455 | 50,431 |
| | Shares | Market Value•
($000) |
| Verisk Analytics Inc. Class A | 231,694 | 48,718 |
* | Axon Enterprise Inc. | 265,860 | 47,844 |
| Vertiv Holdings Co. Class A | 1,784,079 | 45,815 |
* | XPO Logistics Inc. | 512,442 | 43,968 |
| Forward Air Corp. | 430,722 | 43,313 |
* | GXO Logistics Inc. | 485,045 | 43,072 |
* | Shoals Technologies Group Inc. Class A | 1,341,023 | 41,558 |
| ABM Industries Inc. | 895,699 | 39,420 |
* | Cimpress plc | 398,534 | 35,597 |
| HEICO Corp. Class A | 275,721 | 34,653 |
| Robert Half International Inc. | 300,294 | 33,954 |
* | Ameresco Inc. Class A | 360,609 | 29,617 |
| UFP Industries Inc. | 352,870 | 28,875 |
* | Atkore Inc. | 299,355 | 28,298 |
| Booz Allen Hamilton Holding Corp. Class A | 323,563 | 28,105 |
| Rockwell Automation Inc. | 87,469 | 27,938 |
* | ACV Auctions Inc. Class A | 1,434,145 | 27,923 |
* | IAA Inc. | 383,856 | 22,897 |
| EMCOR Group Inc. | 187,448 | 22,773 |
| JB Hunt Transport Services Inc. | 114,725 | 22,623 |
* | CoStar Group Inc. | 250,893 | 21,589 |
| Boise Cascade Co. | 378,230 | 21,415 |
* | AZEK Co. Inc. Class A | 579,264 | 21,253 |
| Allison Transmission Holdings Inc. | 604,542 | 20,168 |
| Terex Corp. | 447,069 | 20,029 |
* | GMS Inc. | 401,251 | 19,874 |
* | Kratos Defense & Security Solutions Inc. | 900,850 | 19,269 |
| AGCO Corp. | 157,238 | 19,216 |
| Tetra Tech Inc. | 104,908 | 18,428 |
| Woodward Inc. | 144,121 | 16,278 |
| Landstar System Inc. | 85,379 | 15,011 |
| Applied Industrial Technologies Inc. | 151,903 | 14,808 |
* | Sterling Check Corp. | 684,340 | 14,679 |
| Allegion plc | 110,219 | 14,141 |
| Heartland Express Inc. | 705,913 | 11,528 |
| Lincoln Electric Holdings Inc. | 79,116 | 11,266 |
* | Saia Inc. | 34,011 | 10,633 |
| Exponent Inc. | 89,232 | 10,244 |
| Franklin Electric Co. Inc. | 118,567 | 10,242 |
| GrafTech International Ltd. | 904,089 | 9,674 |
* | Plug Power Inc. | 249,410 | 9,545 |
* | Upwork Inc. | 197,226 | 9,293 |
* | Avis Budget Group Inc. | 50,177 | 8,696 |
| Simpson Manufacturing Co. Inc. | 81,375 | 8,633 |
* | Textainer Group Holdings Ltd. | 212,950 | 8,367 |
* | Cornerstone Building Brands Inc. | 449,698 | 6,435 |
| Nordson Corp. | 25,243 | 6,417 |
* | TrueBlue Inc. | 216,816 | 6,038 |
* | Atlas Air Worldwide Holdings Inc. | 72,218 | 5,858 |
| Pitney Bowes Inc. | 802,463 | 5,569 |
| Hillenbrand Inc. | 117,790 | 5,355 |
| Primoris Services Corp. | 198,177 | 5,341 |
| Graco Inc. | 68,931 | 5,182 |
* | SPX Corp. | 88,933 | 5,166 |
| | Shares | Market Value•
($000) |
* | ASGN Inc. | 37,249 | 4,457 |
| Mueller Industries Inc. | 76,025 | 4,002 |
* | Meritor Inc. | 135,630 | 3,301 |
| Toro Co. | 32,667 | 3,119 |
* | MYR Group Inc. | 26,235 | 2,680 |
| REV Group Inc. | 168,117 | 2,540 |
| Donaldson Co. Inc. | 41,457 | 2,488 |
| Kforce Inc. | 34,779 | 2,252 |
| Brady Corp. Class A | 41,583 | 2,166 |
| Huntington Ingalls Industries Inc. | 10,058 | 2,039 |
* | American Woodmark Corp. | 20,555 | 1,413 |
* | BlueLinx Holdings Inc. | 20,513 | 977 |
| Werner Enterprises Inc. | 19,260 | 873 |
* | Huron Consulting Group Inc. | 15,382 | 772 |
| Argan Inc. | 15,021 | 620 |
| | | 4,664,400 |
Information Technology (22.1%) |
*,2 | Momentive Global Inc. | 9,194,299 | 210,733 |
* | Five9 Inc. | 1,286,197 | 203,232 |
* | New Relic Inc. | 2,184,644 | 177,306 |
| Monolithic Power Systems Inc. | 280,533 | 147,409 |
| Power Integrations Inc. | 1,329,105 | 137,177 |
* | ON Semiconductor Corp. | 2,799,906 | 134,592 |
* | First Solar Inc. | 1,118,913 | 133,811 |
* | Varonis Systems Inc. Class B | 2,050,895 | 132,775 |
* | HubSpot Inc. | 137,069 | 111,057 |
* | Ziff Davis Inc. | 856,774 | 109,898 |
| Concentrix Corp. | 578,923 | 102,863 |
* | Manhattan Associates Inc. | 554,805 | 100,719 |
* | Cadence Design Systems Inc. | 557,122 | 96,443 |
* | Tower Semiconductor Ltd. | 3,017,577 | 96,170 |
* | Ciena Corp. | 1,663,239 | 90,297 |
* | Silicon Laboratories Inc. | 440,945 | 83,233 |
* | Viavi Solutions Inc. | 5,295,361 | 81,549 |
* | Guidewire Software Inc. | 640,696 | 80,555 |
* | Fortinet Inc. | 232,048 | 78,047 |
| Entegris Inc. | 554,151 | 78,013 |
| Maximus Inc. | 898,393 | 75,977 |
* | GoDaddy Inc. Class A | 1,039,828 | 71,925 |
* | Smartsheet Inc. Class A | 1,031,800 | 71,205 |
* | Enphase Energy Inc. | 287,703 | 66,641 |
* | Everbridge Inc. | 415,373 | 66,173 |
| Belden Inc. | 1,075,651 | 64,765 |
* | Trimble Inc. | 731,697 | 63,928 |
* | Wix.com Ltd. | 343,313 | 63,843 |
* | Dynatrace Inc. | 833,056 | 62,479 |
* | Arrow Electronics Inc. | 538,296 | 62,308 |
* | GLOBALFOUNDRIES Inc. | 1,253,965 | 61,118 |
* | Semtech Corp. | 700,833 | 59,592 |
* | Mandiant Inc. | 3,208,620 | 55,958 |
* | Avalara Inc. | 299,210 | 53,750 |
* | Euronet Worldwide Inc. | 454,489 | 50,989 |
* | Mimecast Ltd. | 662,875 | 50,007 |
* | Sprout Social Inc. Class A | 379,938 | 48,511 |
* | 8x8 Inc. | 2,139,262 | 48,476 |
* | Teledyne Technologies Inc. | 107,510 | 48,296 |
* | Envestnet Inc. | 564,755 | 47,157 |
* | PTC Inc. | 351,536 | 44,768 |
* | Tyler Technologies Inc. | 81,643 | 44,350 |
| | Shares | Market Value•
($000) |
* | Nuance Communications Inc. | 776,573 | 42,750 |
| Jack Henry & Associates Inc. | 253,344 | 42,177 |
* | Palo Alto Networks Inc. | 81,654 | 41,569 |
* | Tenable Holdings Inc. | 768,154 | 40,904 |
* | Paycor HCM Inc. | 1,253,757 | 40,672 |
* | CyberArk Software Ltd. | 224,703 | 40,471 |
* | Informatica Inc. Class A | 1,362,534 | 40,413 |
| Brooks Automation Inc. | 329,135 | 38,328 |
* | MongoDB Inc. Class A | 73,414 | 38,270 |
| Microchip Technology Inc. | 515,012 | 38,157 |
* | IPG Photonics Corp. | 232,761 | 37,011 |
* | Rapid7 Inc. | 284,700 | 36,655 |
| Cognex Corp. | 393,517 | 34,468 |
* | Fair Isaac Corp. | 82,404 | 32,813 |
*,1 | N-Able Inc. | 2,305,242 | 30,660 |
* | Dropbox Inc. Class A | 971,499 | 29,621 |
* | Elastic NV | 170,241 | 29,539 |
* | A10 Networks Inc. | 1,540,105 | 28,785 |
* | WEX Inc. | 191,392 | 28,651 |
| Jabil Inc. | 467,929 | 28,057 |
* | RingCentral Inc. Class A | 113,841 | 27,752 |
| National Instruments Corp. | 652,976 | 27,732 |
* | Teradata Corp. | 486,838 | 27,536 |
* | Zendesk Inc. | 270,216 | 27,508 |
* | Onto Innovation Inc. | 346,299 | 27,430 |
| MKS Instruments Inc. | 181,582 | 27,246 |
* | ANSYS Inc. | 69,172 | 26,256 |
*,1 | Procore Technologies Inc. | 281,000 | 25,697 |
* | Atlassian Corp. plc Class A | 54,325 | 24,888 |
* | ChannelAdvisor Corp. | 963,952 | 24,590 |
* | EPAM Systems Inc. | 35,487 | 23,891 |
* | Nutanix Inc. Class A | 688,378 | 23,618 |
* | Aspen Technology Inc. | 148,164 | 23,216 |
| TTEC Holdings Inc. | 231,974 | 21,896 |
* | Qualys Inc. | 174,109 | 21,673 |
* | Q2 Holdings Inc. | 266,843 | 20,937 |
* | Domo Inc. Class B | 235,975 | 20,848 |
* | Workiva Inc. Class A | 137,586 | 20,576 |
* | Unity Software Inc. | 133,516 | 20,202 |
* | Coupa Software Inc. | 86,418 | 19,677 |
* | DocuSign Inc. Class A | 69,916 | 19,457 |
* | Black Knight Inc. | 275,172 | 19,292 |
* | Alarm.com Holdings Inc. | 218,670 | 18,425 |
* | Consensus Cloud Solutions Inc. | 285,591 | 18,087 |
* | CommScope Holding Co. Inc. | 1,607,387 | 17,215 |
| SolarWinds Corp. | 1,056,943 | 17,017 |
* | Repay Holdings Corp. Class A | 800,562 | 16,820 |
* | Sumo Logic Inc. | 955,172 | 16,496 |
* | Ultra Clean Holdings Inc. | 331,446 | 16,430 |
* | Pure Storage Inc. Class A | 571,614 | 15,354 |
* | PROS Holdings Inc. | 509,666 | 15,290 |
* | Box Inc. Class A | 590,933 | 15,264 |
* | Freshworks Inc. Class A | 297,800 | 14,964 |
* | SentinelOne Inc. Class A | 200,000 | 13,280 |
* | Digital Turbine Inc. | 151,448 | 13,034 |
* | Bill.Com Holdings Inc. | 43,474 | 12,795 |
* | Axcelis Technologies Inc. | 221,954 | 12,192 |
| CDW Corp. | 63,762 | 11,901 |
* | SMART Global Holdings Inc. | 221,794 | 11,857 |
| | Shares | Market Value•
($000) |
* | Avaya Holdings Corp. | 593,540 | 11,052 |
* | Paylocity Holding Corp. | 35,666 | 10,883 |
* | Lattice Semiconductor Corp. | 152,156 | 10,566 |
* | Ichor Holdings Ltd. | 220,818 | 9,654 |
* | Diodes Inc. | 95,389 | 9,166 |
* | Zuora Inc. Class A | 411,505 | 8,996 |
* | Extreme Networks Inc. | 881,306 | 8,663 |
* | Calix Inc. | 137,476 | 8,605 |
* | Anaplan Inc. | 128,054 | 8,350 |
* | Vonage Holdings Corp. | 514,293 | 8,290 |
| CSG Systems International Inc. | 158,429 | 7,929 |
* | CommVault Systems Inc. | 122,747 | 7,549 |
* | Unisys Corp. | 289,663 | 7,407 |
| Amkor Technology Inc. | 336,946 | 7,386 |
* | MACOM Technology Solutions Holdings Inc. Class H | 100,248 | 6,999 |
* | NeoPhotonics Corp. | 677,376 | 6,855 |
| Kulicke & Soffa Industries Inc. | 117,991 | 6,726 |
* | Plantronics Inc. | 247,995 | 6,636 |
* | MaxLinear Inc. | 97,795 | 6,161 |
* | Agilysys Inc. | 127,866 | 6,102 |
* | Ambarella Inc. | 32,816 | 6,098 |
* | Avid Technology Inc. | 203,741 | 5,835 |
| McAfee Corp.Class A | 261,409 | 5,586 |
* | Allegro MicroSystems Inc. | 161,584 | 5,390 |
* | Brightcove Inc. | 524,919 | 5,207 |
| EVERTEC Inc. | 104,732 | 4,735 |
* | Sitime Corp. | 17,186 | 4,552 |
* | eGain Corp. | 440,680 | 4,548 |
* | Diebold Nixdorf Inc. | 476,775 | 4,291 |
| Hackett Group Inc. | 198,772 | 4,202 |
| Advanced Energy Industries Inc. | 45,509 | 4,179 |
* | Cohu Inc. | 128,232 | 4,109 |
* | ePlus Inc. | 36,557 | 4,042 |
| Pegasystems Inc. | 33,682 | 3,999 |
| Progress Software Corp. | 61,785 | 3,176 |
* | FormFactor Inc. | 73,194 | 2,912 |
* | Cambium Networks Corp. | 103,127 | 2,910 |
* | Veritone Inc. | 94,947 | 2,840 |
*,1 | Riot Blockchain Inc. | 96,185 | 2,618 |
*,1 | Eastman Kodak Co. | 382,179 | 2,595 |
* | LiveRamp Holdings Inc. | 44,254 | 2,368 |
* | Super Micro Computer Inc. | 65,149 | 2,306 |
* | ON24 Inc. | 117,797 | 2,254 |
| Genpact Ltd. | 45,152 | 2,228 |
* | Yext Inc. | 165,798 | 2,087 |
* | Globant SA | 6,503 | 2,076 |
* | International Money Express Inc. | 118,414 | 1,982 |
* | Zix Corp. | 220,604 | 1,869 |
* | Duck Creek Technologies Inc. | 54,756 | 1,725 |
* | 3D Systems Corp. | 54,900 | 1,546 |
* | MicroStrategy Inc. Class A | 2,155 | 1,541 |
* | LivePerson Inc. | 26,532 | 1,367 |
* | Insight Enterprises Inc. | 14,117 | 1,337 |
* | Telos Corp. | 51,444 | 1,333 |
* | BigCommerce Holdings Inc. Series 1 | 24,538 | 1,134 |
* | Fabrinet | 10,699 | 1,027 |
| | Shares | Market Value•
($000) |
* | DigitalOcean Holdings Inc. | 10,459 | 1,021 |
* | Grid Dynamics Holdings Inc. | 34,623 | 995 |
* | Asana Inc. Class A | 6,938 | 942 |
* | Turtle Beach Corp. | 30,150 | 867 |
* | Arlo Technologies Inc. | 114,201 | 788 |
* | Mitek Systems Inc. | 37,186 | 700 |
| ADTRAN Inc. | 30,789 | 569 |
| | | 5,448,266 |
Materials (2.0%) |
| Methanex Corp. | 2,284,243 | 102,289 |
| Smurfit Kappa Group plc | 1,917,978 | 100,584 |
| Louisiana-Pacific Corp. | 1,649,384 | 97,198 |
* | Summit Materials Inc. Class A | 1,830,961 | 65,274 |
| Graphic Packaging Holding Co. | 1,370,758 | 27,319 |
| Balchem Corp. | 145,522 | 22,278 |
| Westlake Chemical Corp. | 213,486 | 20,781 |
| Steel Dynamics Inc. | 293,385 | 19,387 |
| Avery Dennison Corp. | 55,235 | 12,026 |
| Trinseo plc | 193,974 | 10,874 |
| Olin Corp. | 133,316 | 7,596 |
| Sensient Technologies Corp. | 49,030 | 4,687 |
* | O-I Glass Inc. | 316,625 | 4,132 |
* | Ingevity Corp. | 49,933 | 3,890 |
| Schnitzer Steel Industries Inc. Class A | 61,147 | 3,290 |
* | Orion Engineered Carbons SA | 141,341 | 2,657 |
| Innospec Inc. | 8,642 | 783 |
| | | 505,045 |
Other (1.3%) |
3 | Vanguard Small-Cap ETF | 1,373,109 | 315,115 |
Real Estate (2.9%) |
| PS Business Parks Inc. | 692,306 | 123,023 |
| Essential Properties Realty Trust Inc. | 2,999,109 | 89,344 |
| VICI Properties Inc. | 2,825,326 | 82,923 |
| Life Storage Inc. | 574,578 | 76,884 |
| Douglas Emmett Inc. | 2,135,110 | 69,775 |
| Pebblebrook Hotel Trust | 2,114,744 | 47,497 |
* | Xenia Hotels & Resorts Inc. | 2,529,999 | 45,034 |
| SBA Communications Corp. Class A | 113,161 | 39,078 |
| CoreSite Realty Corp. | 265,651 | 37,845 |
| Iron Mountain Inc. | 463,141 | 21,138 |
| Americold Realty Trust | 484,600 | 14,281 |
| Lamar Advertising Co. Class A | 125,224 | 14,175 |
| National Storage Affiliates Trust | 186,601 | 11,655 |
* | Redfin Corp. | 195,608 | 10,043 |
| eXp World Holdings Inc. | 115,703 | 5,970 |
* | Ryman Hospitality Properties Inc. | 60,552 | 5,180 |
| GEO Group Inc. | 549,674 | 4,496 |
| JBG SMITH Properties | 142,633 | 4,116 |
| Alexander's Inc. | 9,841 | 2,744 |
| American Finance Trust Inc. | 326,857 | 2,706 |
| RMR Group Inc. Class A | 75,418 | 2,624 |
| | Shares | Market Value•
($000) |
| Tanger Factory Outlet Centers Inc. | 133,774 | 2,247 |
| Outfront Media Inc. | 85,345 | 2,124 |
| Innovative Industrial Properties Inc. | 3,636 | 957 |
| | | 715,859 |
Utilities (0.5%) |
| Atlantica Sustainable Infrastructure plc | 2,379,746 | 93,643 |
| NRG Energy Inc. | 322,044 | 12,846 |
1 | Brookfield Infrastructure Corp. Class A | 54,357 | 3,296 |
| Brookfield Renewable Corp. Class A | 21,140 | 876 |
| American States Water Co. | 8,440 | 767 |
| | | 111,428 |
Total Common Stocks (Cost $15,738,197) | 23,931,436 |
Preferred Stock (0.0%) |
*,1 | Meta Material Inc. 0.000%, 12/28/21 (Cost $267) | 181,756 | 233 |
Temporary Cash Investments (3.3%) |
Money Market Fund (2.5%) |
4,5 | Vanguard Market Liquidity Fund, 0.070% | 6,274,692 | 627,469 |
| | Face Amount ($000) | Market Value•
($000) |
Repurchase Agreement (0.8%) |
| Deutsche Bank Securities Inc. 0.050%, 11/1/21 (Dated 10/29/21, Repurchase Value $190,801,000, collateralized by U.S. Treasury Note/Bond 1.625%–2.000%, 2/15/23–8/15/25, with a value of $194,616,000) | 190,800 | 190,800 |
Total Temporary Cash Investments (Cost $818,173) | 818,269 |
Total Investments (100.3%) (Cost $16,556,637) | 24,749,938 |
Other Assets and Liabilities—Net (-0.3%) | (82,075) |
Net Assets (100%) | 24,667,863 |
Cost is in $000. |
• | See Note A in Notes to Financial Statements. |
* | Non-income-producing security. |
1 | Includes partial security positions on loan to broker-dealers. The total value of securities on loan is $76,359,000. |
2 | Considered an affiliated company of the fund as the fund owns more than 5% of the outstanding voting securities of such company. |
3 | Considered an affiliated company of the fund as the issuer is another member of The Vanguard Group. |
4 | Affiliated money market fund available only to Vanguard funds and certain trusts and accounts managed by Vanguard. Rate shown is the 7-day yield. |
5 | Collateral of $79,231,000 was received for securities on loan. |
| ADR—American Depositary Receipt. |
Derivative Financial Instruments Outstanding as of Period End
Futures Contracts |
| | | ($000) |
| Expiration | Number of Long (Short) Contracts | Notional Amount | Value and Unrealized Appreciation (Depreciation) |
Long Futures Contracts | | | | |
E-mini Russell 2000 Index | December 2021 | 3,058 | 350,951 | 9,272 |
See accompanying Notes, which are an integral part of the Financial Statements.
Statement of Assets and Liabilities
|
($000s, except shares and per-share amounts) | Amount |
Assets | |
Investments in Securities, at Value | |
Unaffiliated Issuers (Cost $15,384,308) | 23,440,493 |
Affiliated Issuers (Cost $1,172,329) | 1,309,445 |
Total Investments in Securities | 24,749,938 |
Investment in Vanguard | 797 |
Cash Collateral Pledged—Futures Contracts | 19,588 |
Receivables for Investment Securities Sold | 93,834 |
Receivables for Accrued Income | 1,601 |
Receivables for Capital Shares Issued | 9,888 |
Variation Margin Receivable—Futures Contracts | 29 |
Total Assets | 24,875,675 |
Liabilities | |
Due to Custodian | 6,801 |
Payables for Investment Securities Purchased | 103,763 |
Collateral for Securities on Loan | 79,231 |
Payables to Investment Advisor | 8,735 |
Payables for Capital Shares Redeemed | 7,588 |
Payables to Vanguard | 1,694 |
Total Liabilities | 207,812 |
Net Assets | 24,667,863 |
At October 31, 2021, net assets consisted of: | |
| |
Paid-in Capital | 13,154,594 |
Total Distributable Earnings (Loss) | 11,513,269 |
Net Assets | 24,667,863 |
|
Investor Shares—Net Assets | |
Applicable to 26,895,565 outstanding $.001 par value shares of beneficial interest (unlimited authorization) | 4,073,750 |
Net Asset Value Per Share—Investor Shares | $151.47 |
|
Admiral Shares—Net Assets | |
Applicable to 146,037,033 outstanding $.001 par value shares of beneficial interest (unlimited authorization) | 20,594,113 |
Net Asset Value Per Share—Admiral Shares | $141.02 |
See accompanying Notes, which are an integral part of the Financial Statements.
|
| Year Ended October 31, 2021 |
| ($000) |
Investment Income | |
Income | |
Dividends—Unaffiliated Issuers1 | 116,446 |
Dividends—Affiliated Issuers | 2,603 |
Interest—Unaffiliated Issuers | 188 |
Interest—Affiliated Issuers | 434 |
Securities Lending—Net | 3,137 |
Total Income | 122,808 |
Expenses | |
Investment Advisory Fees—Note B | |
Basic Fee | 37,530 |
Performance Adjustment | (2,317) |
The Vanguard Group—Note C | |
Management and Administrative—Investor Shares | 9,902 |
Management and Administrative—Admiral Shares | 24,249 |
Marketing and Distribution—Investor Shares | 206 |
Marketing and Distribution—Admiral Shares | 554 |
Custodian Fees | 140 |
Auditing Fees | 45 |
Shareholders’ Reports—Investor Shares | 54 |
Shareholders’ Reports—Admiral Shares | 141 |
Trustees’ Fees and Expenses | 16 |
Total Expenses | 70,520 |
Net Investment Income | 52,288 |
Realized Net Gain (Loss) | |
Investment Securities Sold—Unaffiliated Issuers | 3,260,679 |
Investment Securities Sold—Affiliated Issuers | 104,429 |
Futures Contracts | 151,193 |
Foreign Currencies | 50 |
Realized Net Gain (Loss) | 3,516,351 |
Change in Unrealized Appreciation (Depreciation) | |
Investment Securities—Unaffiliated Issuers | 4,056,065 |
Investment Securities—Affiliated Issuers | 220,212 |
Futures Contracts | 14,816 |
Foreign Currencies | (1) |
Change in Unrealized Appreciation (Depreciation) | 4,291,092 |
Net Increase (Decrease) in Net Assets Resulting from Operations | 7,859,731 |
1 | Dividends are net of foreign withholding taxes of $290,000. |
See accompanying Notes, which are an integral part of the Financial Statements.
Statement of Changes in Net Assets
|
| Year Ended October 31, |
| 2021 ($000) | 2020 ($000) |
| | |
Increase (Decrease) in Net Assets | | |
Operations | | |
Net Investment Income | 52,288 | 58,101 |
Realized Net Gain (Loss) | 3,516,351 | 1,371,327 |
Change in Unrealized Appreciation (Depreciation) | 4,291,092 | 675,466 |
Net Increase (Decrease) in Net Assets Resulting from Operations | 7,859,731 | 2,104,894 |
Distributions | | |
Investor Shares | (250,706) | (178,026) |
Admiral Shares | (1,099,471) | (652,715) |
Total Distributions | (1,350,177) | (830,741) |
Capital Share Transactions | | |
Investor Shares | (480,536) | (483,899) |
Admiral Shares | 2,034,131 | (274,035) |
Net Increase (Decrease) from Capital Share Transactions | 1,553,595 | (757,934) |
Total Increase (Decrease) | 8,063,149 | 516,219 |
Net Assets | | |
Beginning of Period | 16,604,714 | 16,088,495 |
End of Period | 24,667,863 | 16,604,714 |
See accompanying Notes, which are an integral part of the Financial Statements.
Investor Shares | | | | | |
For a Share Outstanding Throughout Each Period | Year Ended October 31, |
2021 | 2020 | 2019 | 2018 | 2017 |
Net Asset Value, Beginning of Period | $110.44 | $101.66 | $102.25 | $102.10 | $83.91 |
Investment Operations | | | | | |
Net Investment Income1 | .206 | .284 | .333 | .325 | .421 |
Net Realized and Unrealized Gain (Loss) on Investments | 49.372 | 13.688 | 8.234 | 11.192 | 21.657 |
Total from Investment Operations | 49.578 | 13.972 | 8.567 | 11.517 | 22.078 |
Distributions | | | | | |
Dividends from Net Investment Income | (.158) | (.295) | (.286) | (.475) | (.318) |
Distributions from Realized Capital Gains | (8.390) | (4.897) | (8.871) | (10.892) | (3.570) |
Total Distributions | (8.548) | (5.192) | (9.157) | (11.367) | (3.888) |
Net Asset Value, End of Period | $151.47 | $110.44 | $101.66 | $102.25 | $102.10 |
Total Return2 | 46.27% | 14.08% | 10.15% | 12.12% | 27.10% |
Ratios/Supplemental Data | | | | | |
Net Assets, End of Period (Millions) | $4,074 | $3,325 | $3,520 | $3,420 | $3,520 |
Ratio of Total Expenses to Average Net Assets3 | 0.40% | 0.41% | 0.45% | 0.44% | 0.43% |
Ratio of Net Investment Income to Average Net Assets | 0.15% | 0.28% | 0.33% | 0.31% | 0.45% |
Portfolio Turnover Rate | 45% | 43% | 41% | 50% | 76% |
1 | Calculated based on average shares outstanding. |
2 | Total returns do not include account service fees that may have applied in the periods shown. Fund prospectuses provide information about any applicable account service fees. |
3 | Includes performance-based investment advisory fee increases (decreases) of (0.01%), (0.01%), 0.03%, 0.02%, and (0.01%). |
See accompanying Notes, which are an integral part of the Financial Statements.
Admiral Shares | | | | | |
For a Share Outstanding Throughout Each Period | Year Ended October 31, |
2021 | 2020 | 2019 | 2018 | 2017 |
Net Asset Value, Beginning of Period | $102.82 | $94.64 | $95.24 | $94.99 | $78.07 |
Investment Operations | | | | | |
Net Investment Income1 | .321 | .365 | .409 | .418 | .495 |
Net Realized and Unrealized Gain (Loss) on Investments | 45.967 | 12.752 | 7.648 | 10.405 | 20.145 |
Total from Investment Operations | 46.288 | 13.117 | 8.057 | 10.823 | 20.640 |
Distributions | | | | | |
Dividends from Net Investment Income | (.275) | (.378) | (.393) | (.438) | (.403) |
Distributions from Realized Capital Gains | (7.813) | (4.559) | (8.264) | (10.135) | (3.317) |
Total Distributions | (8.088) | (4.937) | (8.657) | (10.573) | (3.720) |
Net Asset Value, End of Period | $141.02 | $102.82 | $94.64 | $95.24 | $94.99 |
Total Return2 | 46.42% | 14.21% | 10.27% | 12.24% | 27.25% |
Ratios/Supplemental Data | | | | | |
Net Assets, End of Period (Millions) | $20,594 | $13,279 | $12,569 | $11,616 | $9,514 |
Ratio of Total Expenses to Average Net Assets3 | 0.29% | 0.30% | 0.34% | 0.32% | 0.31% |
Ratio of Net Investment Income to Average Net Assets | 0.25% | 0.39% | 0.44% | 0.43% | 0.57% |
Portfolio Turnover Rate | 45% | 43% | 41% | 50% | 76% |
1 | Calculated based on average shares outstanding. |
2 | Total returns do not include account service fees that may have applied in the periods shown. Fund prospectuses provide information about any applicable account service fees. |
3 | Includes performance-based investment advisory fee increases (decreases) of (0.01%), (0.01%), 0.03%, 0.02%, and (0.01%). |
See accompanying Notes, which are an integral part of the Financial Statements.
Notes to Financial Statements
Vanguard Explorer Fund is registered under the Investment Company Act of 1940 as an open-end investment company, or mutual fund. The fund offers two classes of shares: Investor Shares and Admiral Shares. Each of the share classes has different eligibility and minimum purchase requirements, and is designed for different types of investors.
Market disruptions associated with the COVID-19 pandemic have had a global impact, and uncertainty exists as to the long-term implications. Such disruptions can adversely affect assets of the fund and thus fund performance.
A. | The following significant accounting policies conform to generally accepted accounting principles for U.S. investment companies. The fund consistently follows such policies in preparing its financial statements. |
1. Security Valuation: Securities are valued as of the close of trading on the New York Stock Exchange (generally 4 p.m., Eastern time) on the valuation date. Equity securities are valued at the latest quoted sales prices or official closing prices taken from the primary market in which each security trades; such securities not traded on the valuation date are valued at the mean of the latest quoted bid and asked prices. Securities for which market quotations are not readily available, or whose values have been affected by events occurring before the fund’s pricing time but after the close of the securities’ primary markets, are valued at their fair values calculated according to procedures adopted by the board of trustees. These procedures include obtaining quotations from an independent pricing service, monitoring news to identify significant market- or security-specific events, and evaluating changes in the values of foreign market proxies (for example, ADRs, futures contracts, or exchange-traded funds), between the time the foreign markets close and the fund’s pricing time. When fair-value pricing is employed, the prices of securities used by a fund to calculate its net asset value may differ from quoted or published prices for the same securities.
Investments in Vanguard Market Liquidity Fund are valued at that fund's net asset value.
Temporary cash investments are valued using the latest bid prices or using valuations based on a matrix system (which considers such factors as security prices, yields, maturities, and ratings), both as furnished by independent pricing services.
2. Foreign Currency: Securities and other assets and liabilities denominated in foreign currencies are translated into U.S. dollars using exchange rates obtained from an independent third party as of the fund’s pricing time on the valuation date. Realized gains (losses) and unrealized appreciation (depreciation) on investment securities include the effects of changes in exchange rates since the securities were purchased, combined with the effects of changes in security prices. Fluctuations in the value of other assets and liabilities resulting from changes in exchange rates are recorded as unrealized foreign currency gains (losses) until the assets or liabilities are settled in cash, at which time they are recorded as realized foreign currency gains (losses).
3. Futures Contracts: The fund uses index futures contracts to a limited extent, with the objective of maintaining full exposure to the stock market while maintaining liquidity. The fund may purchase or sell futures contracts to achieve a desired level of investment, whether to accommodate portfolio turnover or cash flows from capital share transactions. The primary risks associated with the use of futures contracts are imperfect correlation between changes in market values of stocks held by the fund and the prices of futures contracts, and the possibility of an illiquid market. Counterparty risk involving futures is mitigated because a regulated clearinghouse is the counterparty instead of the clearing broker. To further mitigate counterparty risk, the fund trades futures contracts on an exchange, monitors the financial strength of its clearing brokers and
clearinghouse, and has entered into clearing agreements with its clearing brokers. The clearinghouse imposes initial margin requirements to secure the fund’s performance and requires daily settlement of variation margin representing changes in the market value of each contract. Any securities pledged as initial margin for open contracts are noted in the Schedule of Investments.
Futures contracts are valued at their quoted daily settlement prices. The notional amounts of the contracts are not recorded in the Statement of Assets and Liabilities. Fluctuations in the value of the contracts are recorded in the Statement of Assets and Liabilities as an asset (liability) and in the Statement of Operations as unrealized appreciation (depreciation) until the contracts are closed, when they are recorded as realized gains (losses) on futures contracts.
During the year ended October 31, 2021, the fund’s average investments in long and short futures contracts represented 2% and 0% of net assets, respectively, based on the average of the notional amounts at each quarter-end during the period.
4. Repurchase Agreements: The fund enters into repurchase agreements with institutional counterparties. Securities pledged as collateral to the fund under repurchase agreements are held by a custodian bank until the agreements mature, and in the absence of a default, such collateral cannot be repledged, resold, or rehypothecated. Each agreement requires that the market value of the collateral be sufficient to cover payments of interest and principal. The fund further mitigates its counterparty risk by entering into repurchase agreements only with a diverse group of prequalified counterparties, monitoring their financial strength, and entering into master repurchase agreements with its counterparties. The master repurchase agreements provide that, in the event of a counterparty's default (including bankruptcy), the fund may terminate any repurchase agreements with that counterparty, determine the net amount owed, and sell or retain the collateral up to the net amount owed to the fund. Such action may be subject to legal proceedings, which may delay or limit the disposition of collateral.
5. Federal Income Taxes: The fund intends to continue to qualify as a regulated investment company and distribute all of its taxable income. The fund’s tax returns are open to examination by the relevant tax authorities until expiration of the applicable statute of limitations, which is generally three years after the filing of the tax return. Management has analyzed the fund’s tax positions taken for all open federal and state income tax years, and has concluded that no provision for income tax is required in the fund’s financial statements.
6. Distributions: Distributions to shareholders are recorded on the ex-dividend date. Distributions are determined on a tax basis at the fiscal year-end and may differ from net investment income and realized capital gains for financial reporting purposes.
7. Securities Lending: To earn additional income, the fund lends its securities to qualified institutional borrowers. Security loans are subject to termination by the fund at any time, and are required to be secured at all times by collateral in an amount at least equal to the market value of securities loaned. Daily market fluctuations could cause the value of loaned securities to be more or less than the value of the collateral received. When this occurs, the collateral is adjusted and settled before the opening of the market on the next business day. The fund further mitigates its counterparty risk by entering into securities lending transactions only with a diverse group of prequalified counterparties, monitoring their financial strength, and entering into master securities lending agreements with its counterparties. The master securities lending agreements provide that, in the event of a counterparty’s default (including bankruptcy), the fund may terminate any loans with that borrower, determine the net amount owed, and sell or retain the collateral up to
the net amount owed to the fund; however, such actions may be subject to legal proceedings. While collateral mitigates counterparty risk, in the event of a default, the fund may experience delays and costs in recovering the securities loaned. The fund invests cash collateral received in Vanguard Market Liquidity Fund, and records a liability in the Statement of Assets and Liabilities for the return of the collateral, during the period the securities are on loan. Collateral investments in Vanguard Market Liquidity Fund are subject to market appreciation or depreciation. Securities lending income represents fees charged to borrowers plus income earned on invested cash collateral, less expenses associated with the loan. During the term of the loan, the fund is entitled to all distributions made on or in respect of the loaned securities.
8. Credit Facilities and Interfund Lending Program: The fund and certain other funds managed by The Vanguard Group ("Vanguard") participate in a $4.3 billion committed credit facility provided by a syndicate of lenders pursuant to a credit agreement and an uncommitted credit facility provided by Vanguard. Both facilities may be renewed annually. Each fund is individually liable for its borrowings, if any, under the credit facilities. Borrowings may be utilized for temporary or emergency purposes, subject to the fund’s regulatory and contractual borrowing restrictions. With respect to the committed credit facility, the participating funds are charged administrative fees and an annual commitment fee of 0.10% of the undrawn committed amount of the facility; these fees are allocated to the funds based on a method approved by the fund’s board of trustees and included in Management and Administrative expenses on the fund’s Statement of Operations. Any borrowings under either facility bear interest at a rate based upon the higher of the one-month London Interbank Offered Rate (or an acceptable alternate rate, if necessary), federal funds effective rate, or overnight bank funding rate plus an agreed-upon spread, except that borrowings under the uncommitted credit facility may bear interest based upon an alternate rate agreed to by the fund and Vanguard.
In accordance with an exemptive order (the “Order”) from the SEC, the fund may participate in a joint lending and borrowing program that allows registered open-end Vanguard funds to borrow money from and lend money to each other for temporary or emergency purposes (the “Interfund Lending Program”), subject to compliance with the terms and conditions of the Order, and to the extent permitted by the fund’s investment objective and investment policies. Interfund loans and borrowings normally extend overnight, but can have a maximum duration of seven days. Loans may be called on one business day’s notice. The interest rate to be charged is governed by the conditions of the Order and internal procedures adopted by the board of trustees. The board of trustees is responsible for overseeing the Interfund Lending Program.
For the year ended October 31, 2021, the fund did not utilize the credit facilities or the Interfund Lending Program.
9. Other: Dividend income is recorded on the ex-dividend date. Non-cash dividends included in income, if any, are recorded at the fair value of the securities received. Interest income includes income distributions received from Vanguard Market Liquidity Fund and is accrued daily. Premiums and discounts on debt securities are amortized and accreted, respectively, to interest income over the lives of the respective securities, except for premiums on certain callable debt securities that are amortized to the earliest call date. Security transactions are accounted for on the date securities are bought or sold. Costs used to determine realized gains (losses) on the sale of investment securities are those of the specific securities sold.
Each class of shares has equal rights as to assets and earnings, except that each class separately bears certain class-specific expenses related to maintenance of shareholder accounts (included in
Management and Administrative expenses) and shareholder reporting. Marketing and distribution expenses are allocated to each class of shares based on a method approved by the board of trustees. Income, other non-class-specific expenses, and gains and losses on investments are allocated to each class of shares based on its relative net assets.
B. | The investment advisory firms Wellington Management Company llp, ClearBridge Investments, LLC, Stephens Investment Management Group, LLC, and ArrowMark Colorado Holdings, LLC, each provide investment advisory services to a portion of the fund for a fee calculated at an annual percentage rate of average net assets managed by the advisor. The basic fees of Wellington Management Company llp and ClearBridge Investments, LLC, are subject to quarterly adjustments based on performance relative to the Russell 2500 Growth Index for the preceding three years. The basic fees of Stephens Investment Management Group, LLC, and ArrowMark Colorado Holdings, LLC, are subject to quarterly adjustments based on performance relative to the Russell 2500 Growth Index for the preceding five years. |
Vanguard provides investment advisory services to a portion of the fund as described below; the fund paid Vanguard advisory fees of $1,302,000 for the year ended October 31, 2021.
For the year ended October 31, 2021, the aggregate investment advisory fee paid to all advisors represented an effective annual basic rate of 0.16% of the fund’s average net assets, before a net decrease of $2,317,000 (0.01%) based on performance.
C. | In accordance with the terms of a Funds' Service Agreement (the “FSA”) between Vanguard and the fund, Vanguard furnishes to the fund corporate management, administrative, marketing, distribution and cash management services at Vanguard’s cost of operations (as defined by the FSA). These costs of operations are allocated to the fund based on methods and guidelines approved by the board of trustees and are generally settled twice a month. |
Upon the request of Vanguard, the fund may invest up to 0.40% of its net assets as capital in Vanguard. At October 31, 2021, the fund had contributed to Vanguard capital in the amount of $797,000, representing less than 0.01% of the fund’s net assets and 0.32% of Vanguard’s capital received pursuant to the FSA. The fund’s trustees and officers are also directors and employees, respectively, of Vanguard.
D. | Various inputs may be used to determine the value of the fund’s investments and derivatives. These inputs are summarized in three broad levels for financial statement purposes. The inputs or methodologies used to value securities are not necessarily an indication of the risk associated with investing in those securities. |
Level 1—Quoted prices in active markets for identical securities.
Level 2—Other significant observable inputs (including quoted prices for similar securities, interest rates, prepayment speeds, credit risk, etc.).
Level 3—Significant unobservable inputs (including the fund’s own assumptions used to determine the fair value of investments). Any investments and derivatives valued with significant unobservable inputs are noted on the Schedule of Investments.
The following table summarizes the market value of the fund’s investments and derivatives as of October 31, 2021, based on the inputs used to value them:
| Level 1 ($000) | Level 2 ($000) | Level 3 ($000) | Total ($000) |
Investments | | | | |
Assets | | | | |
Common Stocks | 23,830,852 | 100,584 | — | 23,931,436 |
Preferred Stock | 233 | — | — | 233 |
Temporary Cash Investments | 627,469 | 190,800 | — | 818,269 |
Total | 24,458,554 | 291,384 | — | 24,749,938 |
Derivative Financial Instruments | | | | |
Assets | | | | |
Futures Contracts1 | 9,272 | — | — | 9,272 |
1 | Includes cumulative appreciation (depreciation) on futures contracts and centrally cleared swaps, if any, as reported in the Schedule of Investments. Only current day’s variation margin is reported within the Statement of Assets and Liabilities. |
E. | Permanent differences between book-basis and tax-basis components of net assets are reclassified among capital accounts in the financial statements to reflect their tax character. These reclassifications have no effect on net assets or net asset value per share. As of period end, permanent differences primarily attributable to the accounting for foreign currency transactions, passive foreign investment companies, and distributions in connection with fund share redemptions were reclassified between the following accounts: |
| Amount ($000) |
Paid-in Capital | 212,761 |
Total Distributable Earnings (Loss) | (212,761) |
Temporary differences between book-basis and tax-basis components of total distributable earnings (loss) arise when certain items of income, gain, or loss are recognized in different periods for financial statement and tax purposes; these differences will reverse at some time in the future. The differences are primarily related to the deferral of losses from wash sales; and the recognition of unrealized gains or losses from certain derivative contracts. As of period end, the tax-basis components of total distributable earnings (loss) are detailed in the table as follows:
| Amount ($000) |
Undistributed Ordinary Income | 832,238 |
Undistributed Long-Term Gains | 2,546,328 |
Capital Loss Carryforwards | — |
Qualified Late-Year Losses | — |
Net Unrealized Gains (Losses) | 8,134,703 |
The tax character of distributions paid was as follows:
| Year Ended October 31, |
| 2021 Amount ($000) | 2020 Amount ($000) |
Ordinary Income* | 167,722 | 60,023 |
Long-Term Capital Gains | 1,182,455 | 770,718 |
Total | 1,350,177 | 830,741 |
* | Includes short-term capital gains, if any. |
As of October 31, 2021, gross unrealized appreciation and depreciation for investments and derivatives based on cost for U.S. federal income tax purposes were as follows:
| Amount ($000) |
Tax Cost | 16,615,235 |
Gross Unrealized Appreciation | 9,036,433 |
Gross Unrealized Depreciation | (901,730) |
Net Unrealized Appreciation (Depreciation) | 8,134,703 |
F. | During the year ended October 31, 2021, the fund purchased $9,961,600,000 of investment securities and sold $9,706,497,000 of investment securities, other than temporary cash investments. |
The fund purchased securities from and sold securities to other Vanguard funds or accounts managed by Vanguard or its affiliates, in accordance with procedures adopted by the board of trustees in compliance with Rule 17a-7 of the Investment Company Act of 1940. For the year ended October 31, 2021, such purchases were $3,091,000 and sales were $11,238,000, resulting in net realized gain of $2,388,000; these amounts, other than temporary cash investments, are included in the purchases and sales of investment securities noted above.
G. | Capital share transactions for each class of shares were: |
| Year Ended October 31, | |
| 2021 | | 2020 |
| Amount ($000) | Shares (000) | | Amount ($000) | Shares (000) |
Investor Shares | | | | | |
Issued | 493,604 | 3,566 | | 459,953 | 5,209 |
Issued in Lieu of Cash Distributions | 244,060 | 1,898 | | 173,422 | 1,675 |
Redeemed | (1,218,200) | (8,679) | | (1,117,274) | (11,398) |
Net Increase (Decrease)—Investor Shares | (480,536) | (3,215) | | (483,899) | (4,514) |
| Year Ended October 31, | |
| 2021 | | 2020 |
| Amount ($000) | Shares (000) | | Amount ($000) | Shares (000) |
Admiral Shares | | | | | |
Issued | 3,692,806 | 28,851 | | 1,845,208 | 19,941 |
Issued in Lieu of Cash Distributions | 1,024,110 | 8,560 | | 603,114 | 6,261 |
Redeemed | (2,682,785) | (20,527) | | (2,722,357) | (29,848) |
Net Increase (Decrease)—Admiral Shares | 2,034,131 | 16,884 | | (274,035) | (3,646) |
H. | Certain of the fund’s investments are in companies that are considered to be affiliated companies of the fund because the fund owns more than 5% of the outstanding voting securities of the company or the issuer is another member of The Vanguard Group. Transactions during the period in securities of these companies were as follows: |
| | Current Period Transactions | |
| Oct. 31, 2020 Market Value ($000) | Purchases at Cost ($000) | Proceeds from Securities Sold ($000) | Realized Net Gain (Loss) ($000) | Change in Unrealized App. (Dep.) ($000) | Income ($000) | Capital Gain Distributions Received ($000) | Oct. 31, 2021 Market Value ($000) |
BioTelemetry Inc. | 87,075 | 1,786 | 149,536 | 50,245 | 10,430 | — | — | — |
Cardtronics plc Class A | 56,987 | — | 126,000 | 21,643 | 47,370 | — | — | — |
Enerpac Tool Group Corp. Class A | NA1 | 4,612 | 653 | 225 | 8,686 | 126 | — | 65,557 |
Houghton Mifflin Harcourt Co. | 18,789 | — | 11,039 | 2,692 | 80,129 | — | — | 90,571 |
Jaws Acquisition Corp. Class A | NA1 | 51,726 | 66,512 | 14,786 | — | — | — | — |
Momentive Global Inc.2 | NA1 | 89,740 | 7,049 | 767 | 20,045 | — | — | 210,733 |
Vanguard Market Liquidity Fund | 456,995 | NA3 | NA3 | 38 | (38) | 434 | — | 627,469 |
Vanguard Small-Cap ETF | 196,329 | 207,999 | 156,836 | 14,033 | 53,590 | 2,477 | — | 315,115 |
Total | 816,175 | | | 104,429 | 220,212 | 3,037 | — | 1,309,445 |
1 | Not applicable—at October 31, 2020, the issuer was not an affiliated company of the fund. |
2 | In June 2021, SVMK Inc. changed its name to Momentive Global Inc. |
3 | Not applicable—purchases and sales are for temporary cash investment purposes. |
I. | Management has determined that no events or transactions occurred subsequent to October 31, 2021, that would require recognition or disclosure in these financial statements. |
Report of Independent Registered Public Accounting Firm
To the Board of Trustees and Shareholders of Vanguard Explorer Fund
Opinion on the Financial Statements
We have audited the accompanying statement of assets and liabilities, including the schedule of investments, of Vanguard Explorer Fund (the "Fund") as of October 31, 2021, the related statement of operations for the year ended October 31, 2021, the statement of changes in net assets for each of the two years in the period ended October 31, 2021, including the related notes, and the financial highlights for each of the five years in the period ended October 31, 2021 (collectively referred to as the "financial statements"). In our opinion, the financial statements present fairly, in all material respects, the financial position of the Fund as of October 31, 2021, the results of its operations for the year then ended, the changes in its net assets for each of the two years in the period ended October 31, 2021 and the financial highlights for each of the five years in the period ended October 31, 2021 in conformity with accounting principles generally accepted in the United States of America.
Basis for Opinion
These financial statements are the responsibility of the Fund’s management. Our responsibility is to express an opinion on the Fund’s financial statements based on our audits. We are a public accounting firm registered with the Public Company Accounting Oversight Board (United States) (PCAOB) and are required to be independent with respect to the Fund in accordance with the U.S. federal securities laws and the applicable rules and regulations of the Securities and Exchange Commission and the PCAOB.
We conducted our audits of these financial statements in accordance with the standards of the PCAOB. Those standards require that we plan and perform the audit to obtain reasonable assurance about whether the financial statements are free of material misstatement, whether due to error or fraud.
Our audits included performing procedures to assess the risks of material misstatement of the financial statements, whether due to error or fraud, and performing procedures that respond to those risks. Such procedures included examining, on a test basis, evidence regarding the amounts and disclosures in the financial statements. Our audits also included evaluating the accounting principles used and significant estimates made by management, as well as evaluating the overall presentation of the financial statements. Our procedures included confirmation of securities owned as of October 31, 2021 by correspondence with the custodian, transfer agent and brokers; when replies were not received from the transfer agent or brokers, we performed other auditing procedures. We believe that our audits provide a reasonable basis for our opinion.
/s/PricewaterhouseCoopers LLP
Philadelphia, Pennsylvania
December 17, 2021
We have served as the auditor of one or more investment companies in The Vanguard Group of Funds since 1975.
Special 2021 tax information (unaudited) for Vanguard Explorer Fund
This information for the fiscal year ended October 31, 2021, is included pursuant to provisions of the Internal Revenue Code.
The fund distributed $1,351,164,000 as capital gain dividends (20% rate gain distributions) to shareholders during the fiscal year.
For nonresident alien shareholders, 100% of short-term capital gain dividends distributed by the fund are qualified short-term capital gains.
The fund distributed $73,964,000 of qualified dividend income to shareholders during the fiscal year.
For corporate shareholders, 10.2% of investment income (dividend income plus short-term gains, if any) qualifies for the dividends-received deduction.
This page intentionally left blank.
The People Who Govern Your Fund
The trustees of your mutual fund are there to see that the fund is operated and managed in your best interests since, as a shareholder, you are a part owner of the fund. Your fund’s trustees also serve on the board of directors of The Vanguard Group, Inc., which is owned by the Vanguard funds and provides services to them.
A majority of Vanguard’s board members are independent, meaning that they have no affiliation with Vanguard or the funds they oversee, apart from the sizable personal investments they have made as private individuals. The independent board members have distinguished backgrounds in business, academia, and public service. Each of the trustees and executive officers oversees 214 Vanguard funds.
Information for each trustee and executive officer of the fund appears below. That information, as well as the Vanguard fund count, is as of the date on the cover of this fund report. The mailing address of the trustees and officers is P.O. Box 876, Valley Forge, PA 19482. More information about the trustees is in the Statement of Additional Information, which can be obtained, without charge, by contacting Vanguard at 800-662-7447, or online at vanguard.com.
Interested Trustee1
Mortimer J. Buckley
Born in 1969. Trustee since January 2018. Principal occupation(s) during the past five years and other experience: chairman of the board (2019–present) of Vanguard and of each of the investment companies served by Vanguard; chief executive officer (2018–present) of Vanguard; chief executive officer, president, and trustee (2018–present) of each of the investment companies served by Vanguard; president and director (2017–present) of Vanguard; and president (2018–present) of Vanguard Marketing Corporation. Chief investment officer (2013–2017), managing director (2002–2017), head of the Retail Investor Group (2006–2012), and chief information officer (2001–2006) of Vanguard. Chairman of the board (2011–2017) and trustee (2009–2017) of the Children’s Hospital of Philadelphia; and trustee (2018–present) and vice chair (2019–present) of The Shipley School.
Independent Trustees
Emerson U. Fullwood
Born in 1948. Trustee since January 2008. Principal occupation(s) during the past five years and other experience: executive chief staff and marketing officer for North America and corporate vice president (retired 2008) of Xerox Corporation (document management products and services). Former president of the Worldwide Channels Group, Latin
America, and Worldwide Customer Service and executive chief staff officer of Developing Markets of Xerox. Executive in residence and 2009–2010 Distinguished Minett Professor at the Rochester Institute of Technology. Director of SPX FLOW, Inc. (multi-industry manufacturing). Director of the University of Rochester Medical Center, the Monroe Community College Foundation, the United Way of Rochester, North Carolina A&T University, and Roberts Wesleyan College. Trustee of the University of Rochester.
Amy Gutmann
Born in 1949. Trustee since June 2006. Principal occupation(s) during the past five years and other experience: president (2004–present) of the University of Pennsylvania. Christopher H. Browne Distinguished Professor of Political Science, School of Arts and Sciences, and professor of communication, Annenberg School for Communication, with secondary faculty appointments in the Department of Philosophy, School of Arts and Sciences, and at the Graduate School of Education, University of Pennsylvania.
F. Joseph Loughrey
Born in 1949. Trustee since October 2009. Principal occupation(s) during the past five years and other experience: president and chief operating officer (retired 2009) and vice chairman of the board (2008–2009) of Cummins Inc. (industrial machinery). Chairman of the board of Hillenbrand, Inc. (specialized consumer services). Director of the V Foundation.
1 Mr. Buckley is considered an “interested person,” as defined in the Investment Company Act of 1940, because he is an officer of the Vanguard funds.
Member of the advisory council for the College of Arts and Letters and chair of the advisory board to the Kellogg Institute for International Studies, both at the University of Notre Dame. Chairman of the board of Saint Anselm College.
Mark Loughridge
Born in 1953. Trustee since March 2012. Principal occupation(s) during the past five years and other experience: senior vice president and chief financial officer (retired 2013) of IBM (information technology services). Fiduciary member of IBM’s Retirement Plan Committee (2004–2013), senior vice president and general manager (2002–2004) of IBM Global Financing, vice president and controller (1998–2002) of IBM, and a variety of other prior management roles at IBM. Member of the Council on Chicago Booth.
Scott C. Malpass
Born in 1962. Trustee since March 2012. Principal occupation(s) during the past five years and other experience: chief investment officer (retired June 2020) and vice president (retired June 2020) of the University of Notre Dame. Assistant professor (retired June 2020) of finance at the Mendoza College of Business, University of Notre Dame, and member of the Notre Dame 403(b) Investment Committee. Member of the board of Catholic Investment Services, Inc. (investment advisors) and the board of superintendence of the Institute for the Works of Religion.
Deanna Mulligan
Born in 1963. Trustee since January 2018. Principal occupation(s) during the past five years and other experience: board chair (2020), chief executive officer (2011–2020), and president (2010–2019) of The Guardian Life Insurance Company of America. Chief operating officer (2010–2011) and executive vice president (2008–2010) of Individual Life and Disability of the Guardian Life Insurance Company of America. Member of the board of the Economic Club of New York. Trustee of the Partnership for New York City (business leadership), Chief Executives for Corporate Purpose, NewYork-Presbyterian Hospital, and the Bruce Museum (arts and science). Member of the Advisory Council for the Stanford Graduate School of Business.
André F. Perold
Born in 1952. Trustee since December 2004. Principal occupation(s) during the past five years and other experience: George Gund Professor of Finance and Banking, Emeritus at the Harvard Business School (retired 2011). Chief investment officer and co-managing partner of HighVista Strategies (private investment firm). Member of the board
(2018–present) of RIT Capital Partners (investment firm). Member of the investment committee of Partners Health Care System.
Sarah Bloom Raskin
Born in 1961. Trustee since January 2018. Principal occupation(s) during the past five years and other experience: deputy secretary (2014–2017) of the United States Department of the Treasury. Governor (2010–2014) of the Federal Reserve Board. Commissioner (2007–2010) of financial regulation for the State of Maryland. Professor (2020–present), Distinguished Fellow of the Global Financial Markets Center (2020–present), and Rubenstein Fellow (2017–2020) at Duke University. Trustee (2017–present) of Amherst College and member of Amherst College Investment Committee (2019–present). Member of the Regenerative Crisis Response Committee (2020–present).
David A. Thomas
Born in 1956. Trustee since July 2021. Principal occupation(s) during the past five years and other experience: president of Morehouse College (2018–present). Professor of business administration, emeritus at Harvard University (2017–2018). Dean (2011–2016) and professor of management (2016–2017) at the Georgetown University McDonough School of Business. Director of DTE Energy Company (2013–present). Trustee of Common Fund (2019–present).
Peter F. Volanakis
Born in 1955. Trustee since July 2009. Principal occupation(s) during the past five years and other experience: president and chief operating officer (retired 2010) of Corning Incorporated (communications equipment) and director of Corning Incorporated (2000–2010) and Dow Corning (2001–2010). Director (2012) of SPX Corporation (multi-industry manufacturing). Overseer of the Amos Tuck School of Business Administration, Dartmouth College (2001–2013). Chairman of the board of trustees of Colby-Sawyer College. Member of the BMW Group Mobility Council.
Executive Officers
Christine M. Buchanan
Born in 1970. Principal occupation(s) during the past five years and other experience: principal of Vanguard. Chief financial officer (2021–present) and treasurer (2017–present) of each of the investment companies served by Vanguard. Partner (2005–2017) at KPMG (audit, tax, and advisory services).
David Cermak
Born in 1960. Principal occupation(s) during the past five years and other experience: principal of Vanguard. Finance director (2019–present) of each of the investment companies served by Vanguard. Managing director and head (2017–present) of Vanguard Investments Singapore. Managing director and head (2017–2019) of Vanguard Investments Hong Kong. Representative director and head (2014–2017) of Vanguard Investments Japan.
John Galloway
Born in 1973. Principal occupation(s) during the past five years and other experience: principal of Vanguard. Investment stewardship officer (September 2020–present) of each of the investment companies served by Vanguard. Head of Investor Advocacy (February 2020–present) and head of Marketing Strategy and Planning (2017–2020) at Vanguard. Deputy assistant to the President of the United States (2015).
Peter Mahoney
Born in 1974. Principal occupation(s) during the past five years and other experience: principal of Vanguard. Controller (2015–present) of each of the investment companies served by Vanguard. Head of International Fund Services (2008–2014) at Vanguard.
Anne E. Robinson
Born in 1970. Principal occupation(s) during the past five years and other experience: general counsel (2016–present) of Vanguard. Secretary (2016–present) of Vanguard and of each of the investment companies served by Vanguard. Managing director (2016–present) of Vanguard. Managing director and general counsel of Global Cards and Consumer Services (2014–2016) at Citigroup. Counsel (2003–2014) at American Express.
Michael Rollings
Born in 1963. Principal occupation(s) during the past five years and other experience: finance director (2017–present) and treasurer (2017) of each of the investment companies served by Vanguard. Managing director (2016–present) of Vanguard. Chief financial officer (2016–present) of Vanguard. Director (2016–present) of Vanguard Marketing Corporation. Executive vice president and chief financial officer (2006–2016) of MassMutual Financial Group.
John E. Schadl
Born in 1972. Principal occupation(s) during the past five years and other experience: principal of Vanguard. Chief compliance officer (2019–present) of Vanguard and of each of the investment companies served by Vanguard. Assistant vice president (2019–present) of Vanguard Marketing Corporation.
Vanguard Senior Management Team
Matthew Benchener | Thomas M. Rampulla |
Joseph Brennan | Karin A. Risi |
Mortimer J. Buckley | Anne E. Robinson |
Gregory Davis | Michael Rollings |
John James | Nitin Tandon |
John T. Marcante | Lauren Valente |
Chris D. Mclsaac | |
Connect with Vanguard®>vanguard.com
Fund Information > 800-662-7447
Direct Investor Account Services > 800-662-2739
Institutional Investor Services > 800-523-1036
Text Telephone for People Who Are Deaf or Hard of Hearing > 800-749-7273
This material may be used in conjunction with the offering of shares of any Vanguard fund only if preceded or accompanied by the fund’s current prospectus.
All comparative mutual fund data are from Morningstar, Inc., unless otherwise noted.
You can obtain a free copy of Vanguard’s proxy voting guidelines by visiting vanguard.com/proxyreporting or by calling Vanguard at 800-662-2739. The guidelines are also available from the SEC’s website, www.sec.gov. In addition, you may obtain a free report on how your fund voted the proxies for securities it owned during the 12 months ended June 30. To get the report, visit either vanguard.com/proxyreporting or www.sec.gov.
You can review information about your fund on the SEC’s website, and you can receive copies of this information, for a fee, by sending a request via email addressed to publicinfo@sec.gov.
Source for Bloomberg indexes: Bloomberg Index Services Limited. Copyright 2021, Bloomberg. All rights reserved.
CFA® is a registered trademark owned by CFA Institute.
© 2021 The Vanguard Group, Inc.
All rights reserved.
Vanguard Marketing Corporation, Distributor.
Q240 122021
Item 2: Code of Ethics.
The Registrant has adopted a code of ethics that applies to the Registrant’s principal executive officer, principal financial officer, principal accounting officer or controller or persons performing similar functions. The Code of Ethics was amended during the reporting period covered by this report to make certain technical, non-material changes.
Item 3: Audit Committee Financial Expert.
All members of the Audit Committee have been determined by the Registrant’s Board of Trustees to be Audit Committee Financial Experts and to be independent: F. Joseph Loughrey, Mark Loughridge, Sarah Bloom Raskin, and Peter F. Volanakis.
Item 4: Principal Accountant Fees and Services.
(a) Audit Fees.
Audit Fees of the Registrant.
Fiscal Year Ended October 31, 2021: $45,000
Fiscal Year Ended October 31, 2020: $39,000
Aggregate Audit Fees of Registered Investment Companies in the Vanguard Group.
Fiscal Year Ended October 31, 2021: $11,244,694
Fiscal Year Ended October 31, 2020: $10,761,407
Includes fees billed in connection with audits of the Registrant, other registered investment companies in the Vanguard complex, The Vanguard Group, Inc., and Vanguard Marketing Corporation.
(b) Audit-Related Fees.
Fiscal Year Ended October 31, 2021: $2,955,181
Fiscal Year Ended October 31, 2020: $2,915,863
Includes fees billed in connection with assurance and related services provided to the Registrant, other registered investment companies in the Vanguard complex, The Vanguard Group, Inc., and Vanguard Marketing Corporation.
(c) Tax Fees.
Fiscal Year Ended October 31, 2021: $2,047,574
Fiscal Year Ended October 31, 2020: $247,168
Includes fees billed in connection with tax compliance, planning, and advice services provided to the Registrant, other registered investment companies in the Vanguard complex, The Vanguard Group, Inc., and Vanguard Marketing Corporation.
(d) All Other Fees.
Fiscal Year Ended October 31, 2021: $280,000
Fiscal Year Ended October 31, 2020: $115,000
Includes fees billed for services related to tax reported information provided to the Registrant, other registered investment companies in the Vanguard complex, The Vanguard Group, Inc., and Vanguard Marketing Corporation.
(e) (1) Pre-Approval Policies. The policy of the Registrant’s Audit Committee is to consider, and, if appropriate, approve before the principal accountant is engaged for such services, all specific audit and non-audit services provided to: the Registrant, other registered investment companies in the Vanguard complex, The Vanguard Group, Inc., and entities controlled by The Vanguard Group, Inc. that provide ongoing services to the Registrant. In making a determination, the Audit Committee considers whether the services are consistent with maintaining the principal accountant’s independence.
In the event of a contingency situation in which the principal accountant is needed to provide services in between scheduled Audit Committee meetings, the Chairman of the Audit Committee would be called on to consider and, if appropriate, pre-approve audit or permitted non-audit services in an amount sufficient to complete services through the next Audit Committee meeting, and to determine if such services would be consistent with maintaining the accountant’s independence. At the next scheduled Audit Committee meeting, services and fees would be presented to the Audit Committee for formal consideration, and, if appropriate, approval by the entire Audit Committee. The Audit Committee would again consider whether such services and fees are consistent with maintaining the principal accountant’s independence.
The Registrant’s Audit Committee is informed at least annually of all audit and non-audit services provided by the principal accountant to the Vanguard complex, whether such services are provided to: the Registrant, other registered investment companies in the Vanguard complex, The Vanguard Group, Inc., or other entities controlled by The Vanguard Group, Inc. that provide ongoing services to the Registrant.
(2) No percentage of the principal accountant’s fees or services were approved pursuant to the waiver provision of paragraph (c)(7)(i)(C) of Rule 2-01 of Regulation S-X.
(f) For the most recent fiscal year, over 50% of the hours worked under the principal accountant’s engagement were not performed by persons other than full-time, permanent employees of the principal accountant.
(g) Aggregate Non-Audit Fees.
Fiscal Year Ended October 31, 2021: $2,327,574
Fiscal Year Ended October 31, 2020: $362,168
Includes fees billed for non-audit services provided to the Registrant, other registered investment companies in the Vanguard complex, The Vanguard Group, Inc., and Vanguard Marketing Corporation.
(h) For the most recent fiscal year, the Audit Committee has determined that the provision of all non-audit services was consistent with maintaining the principal accountant’s independence.
Item 5: Audit Committee of Listed Registrants.
The Registrant is a listed issuer as defined in rule 10A-3 under the Securities Exchange Act of 1934 (“Exchange Act”). The Registrant has a separately-designated standing audit committee established in accordance with Section 3(a)(58)(A) of the Exchange Act. The Registrant’s audit committee members are: F. Joseph Loughrey, Mark Loughridge, Sarah Bloom Raskin, and Peter F. Volanakis.
Item 6: Investments.
Not applicable. The complete schedule of investments is included as part of the report to shareholders filed under Item 1 of this Form.
Item 7: Disclosure of Proxy Voting Policies and Procedures for Closed-End Management Investment Companies.
Not applicable.
Item 8: Portfolio Managers of Closed-End Management Investment Companies.
Not applicable.
Item 9: Purchase of Equity Securities by Closed-End Management Investment Company and Affiliated Purchasers.
Not applicable.
Item 10: Submission of Matters to a Vote of Security Holders.
Not applicable.
Item 11: Controls and Procedures.
(a) Disclosure Controls and Procedures. The Principal Executive and Financial Officers concluded that the Registrant’s Disclosure Controls and Procedures are effective based on their evaluation of the Disclosure Controls and Procedures as of a date within 90 days of the filing date of this report.
(b) Internal Control Over Financial Reporting. There were no significant changes in the Registrant’s Internal Control Over Financial Reporting or in other factors that could significantly affect this control subsequent to the date of the evaluation, including any corrective actions with regard to significant deficiencies and material weaknesses.
Item 12: Disclosure of Securities Lending Activities for Closed-End Management Investment Companies.
Not applicable.
Item 13: Exhibits.
Pursuant to the requirements of the Securities Exchange Act of 1934 and the Investment Company Act of 1940, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.
| VANGUARD EXPLORER FUND |
| | |
BY: | /s/ MORTIMER J. BUCKLEY* | |
| MORTIMER J. BUCKLEY | |
| CHIEF EXECUTIVE OFFICER | |
Date: December 20, 2021
Pursuant to the requirements of the Securities Exchange Act of 1934 and the Investment Company Act of 1940, this report has been signed below by the following persons on behalf of the registrant and in the capacities and on the dates indicated.
| VANGUARD EXPLORER FUND |
| | |
BY: | /s/ MORTIMER J. BUCKLEY* | |
| MORTIMER J. BUCKLEY | |
| CHIEF EXECUTIVE OFFICER | |
Date: December 20, 2021
| VANGUARD EXPLORER FUND |
| | |
BY: | /s/ CHRISTINE BUCHANAN* | |
| CHRISTINE BUCHANAN | |
| CHIEF FINANCIAL OFFICER | |
Date: December 20, 2021
* By: /s/ Anne E. Robinson
Anne E. Robinson, pursuant to a Power of Attorney filed on November 29, 2021 (see File Number 33-64845), a Power of Attorney filed on October 12, 2021 (see File Number 33-23444), and a Power of Attorney filed on August 26, 2021 (see file Number 811-02652), Incorporated by Reference.